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Summary 
The recent Zika virus outbreak highlights the need for low-cost diagnostics that can be rapidly developed 
for distribution and use in pandemic regions. Here, we report a pipeline for the rapid design, assembly and 
validation of cell-free, paper-based sensors for the detection of the Zika virus RNA genome. By linking 
isothermal RNA amplification to toehold switch RNA sensors, we detect clinically relevant 
concentrations of Zika virus sequences and demonstrate specificity against closely related Dengue virus 
sequences. When coupled with a novel CRISPR/Cas9-based module, our sensors can discriminate 
between viral strains with single-base resolution. We successfully demonstrate a simple, field-ready 
sample-processing workflow and detect Zika virus from the plasma of a viremic macaque. Our freeze-
dried biomolecular platform resolves important practical limitations to the deployment of molecular 
diagnostics in the field, and demonstrates how synthetic biology can be used to develop diagnostic tools 
for confronting global health crises.  
 
Introduction 
The emerging outbreak of Zika virus in the Americas has brought this once obscure pathogen to the 
forefront of global healthcare. Mostly transmitted by Aedes aegypti and A. albopictus mosquitoes, Zika 
virus infections have been further spread by international travel, and have expanded to large, heavily 
populated regions of South, Central and North America (Bogoch et al., 2016). Correlations between the 
increase in Zika virus infections and the development of fetal microcephaly (Calvet et al., 2016; Galindo-
Fraga et al., 2015; Victora et al., 2016) and Guillain–Barré syndrome have resulted in the declaration of a 
public health emergency by the World Health Organization (WHO) and a call for fast-tracked 
development of Zika virus diagnostics (Oehler et al., 2014; Smith and Mackenzie, 2016; WHO, 2016). 
 
Synthetic biology is an emerging discipline that has great potential to respond to such pandemics. The 
increasing ability of synthetic biologists to repurpose and engineer natural biological components for 
practical applications has led to new opportunities for molecular diagnostics (Kotula et al., 2014; Lu et al., 
2013; Slomovic et al., 2015). We previously developed two biotechnologies that dramatically lower the 
cost of and technical barriers to the development of synthetic biology-based diagnostics. The first 
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technology, programmable RNA sensors called toehold switches, can be rationally designed to bind and 
sense virtually any RNA sequence (Green et al., 2014). The second technology, a freeze-dried, paper-
based, cell-free protein expression platform, allows for the deployment of these toehold switch sensors 
outside of a research laboratory by providing a sterile and abiotic method for the storage and distribution 
of genetic circuits at room temperature (Pardee et al., 2014). We combined these technologies to create a 
platform for rapidly and inexpensively developing and deploying diagnostic sensors.  
  
In the context of the Zika virus outbreak, the paper-based sensors offer a solution to the critical challenges 
facing diagnosis of the virus. Standard serological approaches, such as antibody detection, are limited in 
diagnostic value due to cross-reactivity in patients that have previously been infected by other flaviviruses 
circulating in the region. As a result, accurate diagnosis requires nucleic acid-based detection methods, 
such as PCR and isothermal nucleic acid amplification (Lanciotti et al., 2008; de M Campos et al., 2016; 
Tappe et al., 2014; Zammarchi et al., 2015). However, such techniques are relatively expensive, require 
technical expertise to run and interpret, and utilize equipment that is incompatible with use in remote and 
low-resource locations where surveillance and containment are critically needed.  
 
Here, we demonstrate the rapid development of a diagnostic workflow for sequence-specific detection of 
Zika virus that can be employed in low-resource settings (Figure 1). We have addressed limitations in the 
practical deployment of nucleic acid-based molecular diagnostics by combining isothermal RNA 
amplification with toehold switch sensors on our freeze-dried, paper-based platform. We automate the 
amplification primer and sensor design process using in silico algorithms and demonstrate a high-
throughput pipeline to assemble and test 48 Zika sensors in less than seven hours. Clinically relevant 
sensitivity is attained using our amplification and detection scheme, and we report no significant detection 
of the closely related Dengue virus. To further increase diagnostic capabilities, we develop a 
CRISPR/Cas9-based module that discriminates between Zika genotypes with single-base resolution. 
Finally, we employ a simple sample-preparation protocol to reliably extract viral RNA, and demonstrate 
robust detection with this scheme using active Zika virus samples. 
 
Results 
In silico toehold switch design 
Toehold switch sensors are programmable synthetic riboregulators that control the translation of a gene 
via the binding of a trans-acting trigger RNA. The switches contain a hairpin structure that blocks gene 
translation in cis by sequestration of the ribosome binding site (RBS) and start codon. Upon a switch 
binding to a complementary trigger RNA, sequestration of the RBS and start codon is relieved, activating 
gene translation (Figure 2A and 2B) (Green et al., 2014). To allow for colorimetric detection of trigger 
RNA sequences, the sensors can be designed to regulate translation of the enzyme LacZ, which mediates 
a color change by converting a yellow substrate (chlorophenol red-β-D-galactopyranoside) to a purple 
product (chlorophenol red).  
 
Toehold switch sensors for sequence-based detection of Zika virus were generated using a modified 
version of the previously developed in silico design algorithm (Supplemental Information) (Green et al., 
2014). The modified algorithm screened the genome of the Zika strain prevalent in the Americas 
(Genbank accession number: KU312312) for regions compatible with RNA amplification and toehold 
switch activation. The selected Zika genome regions were then computationally filtered to eliminate 
potential homology to the human transcriptome and to a panel of related viruses, including Dengue and 
Chikungunya. A total of 24 unique regions of the Zika genome compatible with downstream sensing 
efforts were identified.  
 
Two toehold switches, each utilizing a different design scheme, were designed for each region, resulting 
in a total of 48 sensors. The first design scheme, termed the A series, utilizes a modification to the 
original toehold switch (Green et al., 2014) that reduces the size of the loop domain from 18-nts to 11-nts 
(Figure 2A) to discourage loop-mediated docking of the ribosome and therefore reduce leakage in the 
OFF state. The second design scheme, termed the B series, features a 12-nt loop and incorporates a more 
thermodynamically stable stem in order to lower OFF state gene expression (Figure 2B). 
 
Rapid, in vitro sensor assembly and screening 
In vitro assembly and initial screening of all 48 sensors took place in a seven-hour time period, with low 
costs associated with sensor development (DNA input $20 USD/sensor) and testing ($0.10 - $1/test). All 
48 sensors and 24 targeted genomic regions were assembled in-house using in vitro protocols. Toehold 
switches were constructed by ligating the sensors (~130 nt) to a LacZ reporter element in a single two-
hour PCR-based step. Sensor performance screening to assess each sensor against its respective trigger 
RNA element (Zika genome fragment) was completed using low volume, cell-free transcription and 
translation reactions on paper. We found that 25 (52%) of the 48 sensors produce a fold change of five or 
greater in the presence of the appropriate trigger element (128 - 178 nucleotide regions of the Zika 
genome; Figures 2C, 2D and S1). The top-ranked sensors exhibited activation as high as 34-fold over 
sensor alone (sensor 27B), and were activated in as quickly as 20 minutes after incubation at 37C 
(sensors 7A and 8A). For all sensors, maximum fold change occurred within the first 90 minutes. 
Averaging the LacZ output from sensors not exposed to trigger RNA confirmed that the low background 
design of the series B toehold switch sensors successfully reduced signal leakage (Figure 2D inset).  
 
Assessing and improving Zika sensor sensitivity 
We selected top performing sensors from both the A and B series for trigger RNA titration experiments, 
and found that all chosen sensors were activated with as little as 30 nM of trigger RNA (Figure 3A). The 
sensors displayed a linear response to RNA concentration, providing semi-quantitative information on 
input trigger RNA values (Figure S2A). Additionally, our top three sensors were highly orthogonal to 
each other when challenged with a high dose of trigger RNA from off-target Zika sequences (3000 nM) 
(Figure S2B). 
 
Though the sensors displayed specificity for their respective Zika RNA trigger, they were unable to detect 
clinically relevant RNA concentrations. Zika viral loads have been documented as high as 202 x 106 
copies/ml (365 fM) in urine (Gourinat et al., 2015). However, viral loads in saliva and serum are 
reportedly even lower, with 3 x 106 copies/ml (4.9 fM) (Barzon et al., 2016) documented in patient saliva 
and 2.5 x 106 copies/ml (4.1 fM) (Zika experimental science team) and 7.2 x 105 copies/ml (1.2 fM) 
(Lanciotti et al., 2008) in primate and patient serum respectively. Accordingly, to increase the sensitivity 
of our diagnostic platform, we incorporated an isothermal RNA amplification technique known as 
NASBA (nucleic acid sequence-based amplification) into our workflow (Figure 1).  
 
NASBA is a promising candidate for use with our diagnostic scheme because it is known to be extremely 
sensitive and has a proven track record in field-based diagnostic applications (Cordray and Richards-
Kortum, 2012). The amplification process begins with reverse transcription of a target RNA that is 
mediated by a sequence-specific reverse primer to create an RNA/DNA duplex. RNase H then degrades 
the RNA template, allowing a forward primer containing the T7 promoter to bind and initiate elongation 
of the complementary strand, generating a double-stranded DNA product. T7-mediated transcription of 
the DNA template then creates copies of the target RNA sequence. Importantly, each new target RNA can 
be detected by the toehold switch sensors and also serve as starting material for further amplification 
cycles. NASBA requires an initial heating step (65C), followed by isothermal amplification at 41C 
(Figure 3B) (Guatelli et al., 1990). 
 
NASBA was performed on trigger RNA corresponding to Zika genomic regions for sensors 27B and 32B. 
Trigger RNAs were spiked into either water or human serum (7%) to more closely mimic clinical 
samples. NASBA reactions were run for two hours and then applied to freeze-dried, paper-based sensors. 
We saw detection with Zika sensors from NASBA reactions initiated with as little as 3 fM of trigger RNA 
(Figure 3C), a value within the range of reported patient viral loads. Zika sensor detection of NASBA-
amplified trigger RNA proved to be reliable on samples spiked into either serum or water (Figure S2C). 
Additionally, for reactions initialized with high concentrations of trigger RNA (>300 fM), NASBA 
reaction times could be reduced to as little as 30 minutes (Figure S2D). NASBA reagents are compatible 
with freeze-drying (Figure S2E) and could therefore be easily deployed and utilized alongside our paper-
based sensors. We also demonstrated that NASBA can be run in the absence of the initial heating step 
(65C) (Figure S2F), further reducing the technical and power requirements for deployment. 
 
Moving toward a field-ready diagnostic platform 
To move our experiments toward conditions more representative of those found in clinics worldwide, we 
focused on three key efforts: (1) testing sensor specificity against related viruses that share clinical 
symptoms, partial homology, and geographic range with Zika virus, (2) building a second-generation 
portable, battery-powered reader to provide lab-quality results in low-resource environments, and (3) 
developing a low-cost and tractable method for viral RNA extraction. 
 
Although our sensor design algorithm screened for Zika genomic sequences that are mostly distinct from 
those of related viruses, the targeted Zika sequences do share substantial similarity (51%-59%) with their 
Dengue virus counterparts (Figure S3A and S3B). To test the Zika sensors for possible cross-reactivity, 
we exposed the sensors to regions of the Dengue genome that share a degree of homology with regions 
targeted in the Zika genome. Sensors 27B and 32B were treated with high concentrations of RNA 
amplicons (3000 nM) from either Zika or Dengue genomic regions. As seen in Figure 4A, Dengue RNA 
sequences failed to activate the toehold switch sensors. We also tested our NASBA primer sets for 
specificity to their targeted Zika sequences by applying the NASBA-mediated amplification and paper-
based detection scheme to 300 fM inputs of the Dengue and Zika RNA in human serum (7%). Again, we 
did not see a response to the Dengue RNA sequences, demonstrating robust sequence specificity in our 
amplification and detection scheme (Figure 4B). 
 
As part of our efforts to advance the paper-based sensor platform toward field-ready diagnostics, we 
designed a second-generation portable electronic reader to serve as an accessible, low-cost companion 
technology that provides robust and quantitative measurements of sensor outputs. The electronic reader 
was assembled using readily available consumer components, open-source code, and laser-cut acrylic 
housing, with a total cost of just under $250 (Figure S4 and Table S3). The reader is powered by a lithium 
ion battery (18.5 hours) that can be re-charged via micro USB, and houses onboard data storage (4 GB) to 
resolve the need for an attached laptop during diagnostic reads (Pardee et al., 2014). To achieve sensitive 
detection of toehold switch signal output, an acrylic chip that holds the freeze-dried, paper-based 
reactions is placed into the reader between an LED light source (570 nm) and electronic sensors (Figure 
S4B). Using onboard electronics, each sample is read 29 times per minute, providing low-noise 
measurements of changes in light transmission due to LacZ-mediated color change. 
 
To demonstrate the utility of the companion reader, we monitored detection of 1 fM and 3 fM of Zika 
RNA amplicons that had been amplified in NASBA reactions for 2.5 hours. The reader detected 
significant signal from both samples, which are within the reported range of Zika virus in patient serum 
(1.2 fM) and urine (365 fM) (Gourinat et al., 2015; Lanciotti et al., 2008), after just over 20 minutes 
(Figure 4C). 
 
Our next challenge was to develop a technique to release RNA from the viral capsid using simple 
methodology compatible with low-resource environments. To this end, we tested the efficacy of boiling 
viral samples to break down the capsid. For initial development, we engineered lentivirus, which is also 
an RNA virus, to encapsulate the regions of either the Zika or Dengue genomes that correspond to the 
sensor 32B target sequence (Figure S3B). These proxy Zika and Dengue viruses were spiked into human 
serum (7%) at a final concentration of 3 fM, and heated to 95C for either one or two minutes. The 
resulting lysates were then immediately used to initiate NASBA reactions, in order to simulate what 
might be recovered from a patient sample. Boiling the viral samples for one minute was sufficient to 
release detectable amounts of RNA in our amplification and toehold switch detection scheme (Figure 
S3C). NASBA reactions from two-minute boiled samples were also monitored for sensor activation on 
the portable electronic reader. We detected strong sensor activation in less than 30 minutes from 3 fM of 
lentivirus carrying Zika RNA. We were also able to demonstrate clear discrimination between lentiviruses 
containing Zika and Dengue RNA sequences (Figure 4D). 
 
A NASBA-CRISPR cleavage assay to discriminate between Zika strains 
During epidemic outbreaks, it is often valuable to monitor pathogen lineage and geographic spread. In 
some cases, genetic variants may be responsible for different clinical manifestations of infection. For 
example, the Zika strain found in Brazil has been uniquely connected with higher incidences of fetal 
microcephaly and Guillain-Barre syndrome (Calvet et al., 2016; Mlakar et al., 2016). To allow for strain-
specific detection and tracking, we developed an assay that provides single-base discrimination in a 
manner that is compatible with our freeze-dried sensor platform. Our assay, which we term NASBA-
CRISPR Cleavage (NASBACC), leverages the sequence-specific nuclease activity of CRISPR/Cas9 to 
discriminate between viral lineages (Figure 5A). To do this, NASBACC exploits the ability of Cas9 to 
selectively cleave DNA only in the presence of an NGG protospacer adjacent motif (PAM). Since any 
non-biased mutation has a 48% probability of either creating a new PAM site or destroying an existing 
one (Table S4), there are many strain-specific PAM sites that can be used for lineage discrimination 
(Figure 5B and 5C). In the NASBACC detection scheme, RNA sequences undergo NASBA amplification 
utilizing a reverse primer designed to append the trigger sequence of a synthetic toehold switch (sensor H, 
Figure 5A) (Pardee et al., 2014). In the presence of the appropriate PAM sequence and guide RNA target 
site, the double-stranded DNA that is synthesized as part of the NASBA reaction undergoes Cas9-
mediated cleavage, resulting in a truncated RNA product that is unable to activate the sensor H toehold 
switch. In the absence of the PAM sequence, the full-length RNA product containing the sensor H trigger 
sequence is generated, allowing for sensor H activation. Trigger RNA is only amplified from DNA that is 
not cut by Cas9, thereby allowing for strain-specific detection using toehold sensor H.  
 
Using the paper-based system, sensor 32B was able to distinguish between Zika and Dengue RNA 
sequences. However, this sensor could not discriminate between the African (Genbank accession number: 
KF268950) and American (Genbank accession number: KU312312) Zika variants (Figure 5D), a feature 
which may be useful in certain diagnostic applications. To address this, we applied our NASBACC 
detection scheme to discriminate between the African and American Zika strains. Due to a single-base 
difference in the trigger regions of these two strains, a PAM site only exists in the American-lineage 
sequence (Figure 5C). Thus, only the American strain sequence was cleaved by Cas9, which led to 
amplification of truncated RNA that did not activate the sensor H toehold switch (Figure 5E). Conversely, 
the African strain sequence does not contain the PAM site and was not cleaved by Cas9, which resulted in 
amplification of full-length RNA that activated the sensor H toehold switch. Incorporating NASBACC 
into our diagnostic workflow can provide precise genotypic information within a few hours. As with the 
other biomolecular elements of this workflow, Cas9 is compatible with lyophilization and could be used 
in the field (Figure S5).  
 
Diagnostic workflow validation with active Zika virus 
We next sought to validate our sensor platform with live Zika virus. First, we verified that our 
amplification and detection scheme could successfully detect full-length genomic RNA purified from 
Zika virus (Uganda strain MR 766) (Figure 6A). We designed new NASBA primers to accommodate 
sequence differences between the Uganda Zika strain (Genbank accession number: AY632535) and the 
American Zika strain (Genbank accession number: KU312312) that our sensors and primers had 
originally been designed to detect. Computational analysis suggested that Uganda-lineage Zika RNA 
would activate sensor 32B despite two base mismatches in the toehold region, and this was confirmed 
experimentally (Figure 6A). We also demonstrated sensor orthogonality to full-length genomic Dengue 
RNA isolated from three different Dengue serotypes using these methods (Figure 6A).  
 
Once we confirmed that the sensors behaved as expected on full-length genomic RNA, we sought to 
validate the sample preparation scheme and diagnostic workflow from start to finish. Active Zika virus 
was cultured in the laboratory and spiked into human serum (7%) at a final concentration of 10 fM, to 
mimic a clinical sample. The viral sample was then heated to 95C for two minutes, and the resulting 
lysate was subjected to NASBA amplification for three hours. Sensor activation from the NASBA-
amplified viral sample was monitored on the portable electronic reader. We successfully detected 
activation of sensor 32B from a diagnostic workflow initiated with live Zika virus (Figure 6B). 
 
For the final validation of our system, we acquired and tested plasma samples from a viremic macaque 
infected with Zika virus (Genbank accession number: KJ776791) (Zika experimental science team). The 
macaque was found to have a plasma viral load of 1.7 x 106 copies/ml (2.8 fM) by a standard qRT-PCR 
protocol, which was within the detection limits of our platform as tested on synthetic RNA amplicons 
(Figure 4C). The viremic plasma was diluted 1:10 in water to reduce known inhibitory effects of plasma 
on downstream reactions, and was then taken through our sample processing and diagnostic workflow. 
The sample was heated to 95C for two minutes and then amplified via NASBA for three hours. Paper-
based reactions were monitored on the portable electronic reader, and showed strong activation with both 
sensors 27B and 32B in less than 30 minutes (Figure 6C and 6D). 
 
Discussion 
Rapid sensor development pipeline for low-resource molecular diagnostics  
We have devised a rapid diagnostic development pipeline in response to the ongoing Zika virus outbreak. 
The serious but poorly understood complications of this viral infection make its timely diagnosis critical 
for patient health and for limiting its rapid proliferation. However, the poor performance of antibody 
detection methods (Lanciotti et al., 2008; de M Campos et al., 2016; Tappe et al., 2014; Zammarchi et al., 
2015) and the limitations of traditional sequence-based diagnostics have left technical and economic 
challenges to meeting diagnostic needs. 
 
Our paper-based platform directly addresses these needs by enabling sequence-specific detection of Zika 
virus in a low-cost manner that is tractable in low-resource settings. By freeze-drying cell-free 
transcription and translation systems with genetic sensors onto paper, we have created a sterile and abiotic 
platform that can be utilized outside of laboratory conditions without concern over biosafety. 
Furthermore, the freeze-dried biomolecular components remain stable at room temperature, allowing for 
easy storage and distribution in global settings. Our application is easy to use, relying on a colorimetric 
output that can be read by the naked eye or with a low-cost, battery-operated companion reader, and we 
are actively working to improve field-readiness via development of a third-generation reader with 
onboard capabilities for sample preparation and incubation.  
 
The streamlined sensor development platform we describe here provides a generalizable method for a 
rapid response to any emerging outbreak. Our automated design process computationally screens for 
sequence specificity and feeds into a high-throughput protocol for rapid sensor prototyping in vitro. We 
augmented our diagnostic sensors with an upstream target-amplification scheme that allows for detection 
of target sequences in the low femtomolar range, bringing sensor sensitivity in line with in-patient virus 
concentrations (Gourinat et al., 2015; Lanciotti et al., 2008). Additionally, we demonstrated that simply 
boiling an RNA virus liberates sufficient material for downstream amplification and detection processes 
(Figures 4D, 6 and S3C), and we developed a CRISPR-based tool for accurate strain genotyping on paper 
(Figure 5). Finally, our methods were validated on viremic plasma samples (Figure 6C and 6D), 
demonstrating a level of sensitivity that would be required for use of this diagnostic scheme in the field.   
 
Isothermal RNA amplification and nucleic acid-based diagnostics for low-resource settings  
Our unique approach of linking NASBA to a downstream synthetic gene network for output detection can 
be applied to any nucleic acid amplification scheme. This innovative development addresses several key 
technical and economic challenges in the employment of isothermal amplification methods in the field. 
Namely, although NASBA has exceptional sensitivity to low-level infections, the technique is costly ($5-
$20/test) and susceptible to contamination that can lead to off-target products and false positives (Casper 
et al., 2007; Cordray and Richards-Kortum, 2012; Ulrich et al., 2010). Our diagnostic scheme addresses 
both of these points and brings NASBA closer towards application in low-resource settings. The low 
volume paper-based reactions only use a fraction of a microliter of NASBA product ($0.51/l), 
significantly reducing the total cost of NASBA per test. Additionally, linking NASBA to a synthetic gene 
network for signal detection allows for rapid and sensitive output reads in a cost-effective manner ($0.10 - 
$1/test) that is practical for use in low-resource settings. Furthermore, the chance for false positive results 
due to contamination is minimized by the use of sequence-specific toehold switch sensors and 
CRISPR/Cas9-mediated selection downstream of the amplification. Our ability to eliminate the initial 
65°C heating step (Figure S2F) traditionally used in NASBA reactions streamlines the diagnostic protocol 
for in-field use and reduces the requirements of the hardware necessary for monitoring results. Finally, we 
have shown that NASBA reagents can be freeze-dried (Figure S2E) and therefore could be distributed 
around the world at room temperature alongside our toehold switch sensors. We are also actively working 
towards combining NASBA and toehold switch sensor reactions in a one-pot assay that will further 
streamline the diagnostic protocol and shorten the timeframe for readout.   
 
We note that certain components within blood are known to inhibit PCR (Schrader et al., 2012) and 
similarly affect all nucleic acid based diagnostics, including NASBA. However, we found that a simple 
dilution of serum or plasma into water sufficiently removes this effect in our diagnostic scheme. We 
therefore used diluted human serum (7%) as a matrix for our exploratory experiments, and diluted viremic 
plasma samples (10%) for our final validation experiment. The dilution step does affect the overall 
sensitivity of the diagnostic platform, but we have shown that increasing the NASBA reaction time can 
sufficiently compensate for reduced sensitivity. Indeed, we were able to detect 2.8 fM of Zika virus from 
plasma samples from an infected rhesus macaque using our dilution protocol (Figure 6C and 6D). 
Additionally, a recent study found that Zika virus can be detected at high concentrations in saliva (Barzon 
et al., 2016), which may not inhibit nucleic acid amplification to the same extent as blood. We are 
actively working to test other clinical matrices for compatibility with our diagnostic platform. 
 
A robust and field-ready sample preparation scheme for RNA viruses 
In this work, we implemented a simple procedure to extract viral RNA that does not require specialized 
laboratory equipment. By simply boiling (95°C) virus samples for two minutes, we were able to extract 
sufficient quantities of RNA for amplification and detection in our diagnostic platform (Figure 4D and 
6B, 6C, and 6D). We note that we worked quickly to transfer boiled viral samples to NASBA reactions 
that contained RNase inhibitors to protect the integrity of the viral RNA. In practice, other commercially 
available reagents could be added to the sample to protect the RNA from degradation upon collection. Of 
note, we were able to reliably extract RNA from three different sample types using our methodology: 
engineered lentivirus (Figure 4D), cultured Zika virus (Figure 6B) and plasma from an infected rhesus 
macaque (Figure 6C and 6D), highlighting the robustness of our sample preparation scheme.       
 
Programmability of molecular sensors can address rapidly changing diagnostic needs 
Our platform provides multiple levels of molecular programmability that greatly improve diagnostic 
specificity. Both the toehold switches and NASBA primers can be designed to target regions specific to a 
given genome, while excluding regions with significant homology to other organisms. We demonstrated 
the effectiveness of this design algorithm with sensor 32B, which was able to distinguish genomic Zika 
RNA from the genomic RNA of three different Dengue serotypes (Figure 6A). Additionally, the 
NASBACC module allows for single-base discrimination and can be rationally designed to distinguish 
between different genotypes, adding to the overall programmability of our platform (Figure 5E). Given 
the high sensor success rate and low barriers to development, we envision that sensors could be easily 
multiplexed to ensure high confidence diagnosis (reducing both false negative and false positive results) 
while keeping costs low. Furthermore, the diagnostic platform could be deployed as panels that include 
sensors for strain-specific identification and related infections to help monitor the spread of illness. 
 
However, in some cases, it is beneficial for a diagnostic platform to be able to tolerate genetic mutations 
within a particular nucleic acid sequence. Evolutionary drift, for example, is an unavoidable feature of our 
ongoing arms race with pathogens that all molecular diagnostics must confront. Our assay in particular 
has the capacity to tolerate the expected genetic variation found in nature. We analyzed the binding 
between the toehold switch 32B and RNA sequences from homologous regions in Zika strains isolated 
from Africa and Asia (Supplemental Information: Extended Experimental Procedures). Both of these 
strains are predicted to fully activate the toehold sensors, even with up to 4-nt (11%) mismatches. In fact, 
we were able to demonstrate this using RNA triggers from the American strain, two different African 
strains and an Asian-lineage of the virus (Figure 5D and 6). Additionally, a critical feature of our 
technology is the ability to rapidly and inexpensively prototype new genetic sensors, thus allowing for a 
rapid response to genetic variations and mutations as they arise. 
 
Freeze-dried biomolecular networks for addressing real-world issues in real time 
With our goal of responding to the ongoing outbreak in a timely manner, we began our work using 
synthetic RNA fragments spiked into human serum, followed by engineered lentiviruses to mimic clinical 
samples. As with many proof-of-concept diagnostic studies, synthetic samples provided us with a 
powerful tool for optimizing our sensor platform ahead of the regulatory demands required for use of live 
pathogens (Antunes et al., 2015; Crannell et al., 2014; Rohrman et al., 2012; Stefan et al., 2016; Yen et 
al., 2015). Through collaborative efforts with the Zika virus community, we were able to test our platform 
on live Zika virus, and were pleased to find similar detection thresholds with Zika virus isolated from 
infected Vero cells (Figure 6B) and plasma samples from an infected rhesus macaque (Figure 6C and 
6D). Our rapid response to the ongoing Zika virus outbreak and our ability to achieve clinically relevant 
sensitivity and specificity highlight the utility and practicality of this platform technology. 
 
Our synthetic biology pipeline for rapid sensor design and prototyping could be applied to a broad range 
of public health threats, allowing for rapid development of new diagnostics when and where they are most 
needed. The ease of in vitro sensor synthesis will allow for the widespread use of validated sensor 
sequences, aiding rapid global responses to current and future health crises. Finally, our ability to 
expeditiously design and implement our biomolecular diagnostics for an emerging pathogen using the 
engineering principles of synthetic biology suggests that the field will play an ever-increasing role in the 
support and improvement of human health. 
 
Experimental Procedures  
In silico sensor design and DNA synthesis 
A set of 48 toehold switch sensors and corresponding NASBA primers were generated using an integrated 
in silico design algorithm. See the Extended Experimental Procedures section in the Supplemental 
Information for details.  
 
DNA sensor assembly 
Toehold switch constructs were amplified from DNA templates (Integrated DNA Technologies) and 
ligated to the lacZ reporter gene via PCR. Plasmids were constructed for characterization of the top six 
toehold switches (Figure 3A). The DNA templates were amplified using PCR and inserted into pET 
system parent plasmids (EMD Millipore) using Gibson assembly (Gibson et al., 2009) with 30 bp overlap 
regions. Plasmids for sensors 27B and 32B are available through Addgene (plasmid numbers: 75006 – 
75011). 
 Cell-free reactions 
Details of RNA sensor validation are described in Pardee et al. (2014). Briefly, amplified sensor DNA 
was column purified and tested on paper discs (2 mm) containing freeze-dried, cell-free reactions (NEB, 
PURExpress) in the presence or absence of trigger RNA coding for a complementary region of the Zika 
virus genome (128 – 178 nts). The cell-free reactions consisted of: NEB Solution A (40%) and B (30%), 
chlorophenol red--D-galactopyranoside (Sigma, 0.6 mg/ml), RNase inhibitor (Roche, 03335402001; 
0.5%), and linear DNA constructs encoding the toehold sensors (0.33 nM). The paper discs (Whatman, 
1442-042) were blocked in 5% BSA overnight prior to use. Trigger RNA was produced using T7 RNAP-
based transcription (Epicentre ASF3257) from linear DNA templates.  Paper-based reactions (1.8 l) 
were incubated at 37C using either our companion electronic reader inside a humidified chamber or a 
plate reader (BioTek Neo). For the in-house reader, paper discs were placed into 2 mm holes in a 
removable acrylic chip; for the plate reader, paper discs were placed into black, clear bottom 384-well 
plates (Corning 3544).    
 
NASBA 
For NASBA reactions, the trigger elements (128 – 178 nts) were extended by 100 nts on the 5’ and 3’ 
ends with the relevant Zika genome sequence to provide suitable template RNAs. RNA amplicons were 
spiked into 7% human serum (Sigma H4522) where indicated. Reaction Buffer (Life Sciences NECB-24; 
33.5%), Nucleotide Mix (Life Sciences NECN-24; 16.5%), RNase inhibitor (Roche, 03335402001; 
0.5%), 12.5 µM of each NASBA primer (2%), nuclease free water (2.5%), and RNA amplicon (20%) 
were assembled at 4C and incubated at 65C for 2 min, followed by a 10-min incubation at 41C. 
Enzyme Mix (Life Sciences NEC-1-24; 25%) was then added to the reaction (for a final volume of 5uL), 
and the mixture was incubated at 41C for 2 hours unless noted otherwise. For output reads with paper-
based toeholds, the NASBA reactions were diluted 1:7 in water. See Table S2 for primer sequences. 
 
Lentivirus preparation and processing 
HEK293FT cells (Life Technologies, R70007) used for virus packaging were cultured in DMEM 
supplemented with 10% FBS, 1% penicillin-streptomycin, and 4 mM GlutaMAXTM (ThermoFisher 
Scientific). Twelve hours prior to transfection, 6.5 x 106 cells were seeded in a 10 cm dish. 7.5 µg 
psPAX2, 2.5 µg pMD2.G, and 10 µg pSB700 modified to include a Zika or Dengue RNA fragment were 
transfected using the HeBS-CaCl2 method. Media was changed 12 hours post-transfection. Twenty-seven 
hours after changing media, viral supernatant was harvested and filtered using a 0.45 m syringe filter.  
Viral supernatant was then purified with ViraBind Lentivirus Purification Kit (Cell Biolabs VPK-104) 
and buffer exchanged into 1xPBS with Lenti-X Concentrator (Clontech, 631231). Viral RNA 
concentration was quantified using QuickTiter Lentivirus Quantification Kit (VPK-112). Virus samples 
were spiked into 7% human serum at a final volume of 25 µl. Samples were heated to 95C for 1 and 2 
min and used as input to NASBA. 
 
Zika virus preparation and processing 
100 µl of Zika virus isolate (MR 766) was utilized for infection of 106 Vero cells in 4 ml of media 
(DMEM supplemented with 2% fetal calf serum (FCS) and penicillin-streptomycin). The supernatant was 
removed after 2 h of incubation at 37C and replaced with fresh media (DMEM, 10% FCS) for 48 h of 
infection. Cell debris was removed by centrifugation at 1500 rcf for 10 minutes, and aliquots of the virus 
were stored at -80C until use. The virus was buffer exchanged into 1xPBS with Lenti-X Concentrator 
(Clontech, 631231). Viral RNA concentrations were determined from virus purified with the QIAamp 
Viral RNA Mini Kit (Qiagen 52904), and confirmed with qRT-PCR. The titer of the Zika virus used was 
6.7 x 107 infectious units per milliliter (Lambeth et al., 2005). Virus samples were spiked into 7% human 
serum at a final volume of 30 µl. Samples were heated to 95C for 2 min and used as input to NASBA. 
NASBA primers were re-designed to accommodate the MR 766 strain sequence (see Supplemental 
Information).  
 
Dengue orthogonality  
Genomic RNA from three Dengue serotypes was purified using the QIAamp Viral RNA Mini Kit 
(Qiagen 52904). Dengue 1 (Genbank accession number: KM204119), Dengue 2 (Genbank accession 
number: KM204118), Dengue 4 (Genbank accession number: AF326573). NASBA reactions using the 
sensor 32B primer set were performed on 30 pM RNA for 2 h. NASBA reactions were diluted 1:7 in 
water and used to rehydrate freeze-dried, paper-based reactions containing sensor 32B. 
 
Electronic optical reader 
The portable device consists of four layers housed within a laser-cut acrylic box fastened together with 
metal screws and mounting brackets (Figure S4; McMaster-Carr, 8505K14, 98164A061; Digi-Key, 36-
621-ND). The top layer holds a multiplexer (Sparkfun, BOB-09056), solderable breadboard (Sparkfun, 
PRT-12702), friction lock connectors (Digi-Key, A31001-ND, A19473-ND) and 16 LEDs (Digi-Key, 
754-1262-ND). The LEDs have a very narrow viewing angle and an emission of 570 nm to match the 
absorbance maximum of the chlorophenol red product from the LacZ reaction. The LEDs were placed in 
close proximity to the chip in the middle layer, which holds 16 paper disks within 2 mm apertures. The 
apertures prevented transmission of stray light and were coaxial with the LEDs in the top layer and the 
array of 16 TSL2591 sensors (Adafruit, 1980) in the third layer below, which also contained two 
solderable breadboards and connectors as above. The bottom layer contains the Arduino Uno with an 
attached Power Shield (Adafruit, 2708) connected to a rechargeable 2000 mAh lithium ion battery 
(Adafruit, 2011) on which a data-logging shield (Adafruit, 1141) was stacked with connectors (Digi-Key, 
A30954-ND, A19476) and a 4GB SD/MicroSD Card (Adafruit, 102). To prevent crosstalk between reads, 
reactions were read in series by sequentially activating each LED and sensor pair. The read frequency and 
pattern of the reader can be easily adjusted by modifying and uploading alternative sketches to the 
Arduino. The raw data (which is the median of 29 100 ms, 428x gain reads per minute) was saved to the 
SD card along with the date and time of the run, integration time and gain settings. The data were 
processed with the MATLAB script and graphed in Prism. A diagram of the circuit and an overview of 
the laser cut parts can be found in the supplemental figures (Figure S4) and laser cutting patterns, the 
Arduino sketch and MATLAB script are provided as Supplemental information files. 
 
Calculation of fold change 
The calculation of fold change for plate reader data was done by first subtracting the background 
absorbance measured from paper-based reactions that did not contain sensor DNA or trigger RNA. These 
normalized values were smoothed to reduce measurement noise using a three-point average of the time 
point and the data collected 10 minutes before and after. The minimum value of each well was then 
adjusted to zero.  For data presented in Figures 3, 4 and 6, fold change was calculated from these zero 
adjusted values by dividing the wells at each time point by the average signal from the corresponding 
sensor-alone control wells. For our initial sensor screen (Figure 2), we used a more sensitive measure of 
fold change based on the difference in the rate of color change between control and RNA trigger wells. 
This was done by calculating the rate of change in normalized absorbance (570 nm) values using slope; 
where, at each 10 min time point, the rate was calculated using Sn = (Tn+1 - Tn)/10, where T is the 
normalized data at a time point (Tn) and the time point 10 min later (Tn+1), and Sn is the slope reported for 
Tn. Fold change was then calculated as above. 
 
NASBA-CRISPR Cleavage (NASBACC)  
Reactions were performed in a 5 µl volume containing (NASBA buffer), 1 µl of a 250 nM Cas9 nuclease 
(NEB, M0386) and 250 nM purified gRNA (GeneArt precision gRNA synthesis kit, ThermoFisher 
Scientific, A29377) mix, 3 nM NASBACC primers, and 0.4 units of RNAse inhibitor (NEB, M0314). 
The forward NASBACC primer is composed of the reverse complement of the trigger H sequence (5’- 
GTT TGA ATG AAT TGT AGG CTT GTT ATA GTT ATG TTT-3’) and the forward binding sequence 
of the (region 32) NASBA primers. The reverse NASBACC primer contains the T7 promoter sequence 
(5'-CTA ATA CGA CTC ACT ATA GG-3’) followed by the reverse binding sequence of the (region 32) 
NASBA primers. The assembled reaction was incubated at 37°C for 2-6 h. For toehold activation assay 
on freeze-dried paper, NASBACC reactions were diluted 1:10 in nuclease-free water.  
 
Viremic plasma processing 
Details on macaque care and infection can be found in the extended experimental procedures. For 
processing, plasma was diluted 1:10 in nuclease free water, heated to 95C for two minutes and 
immediately added to a NASBA reaction. NASBA was run for three hours.  
 
Quantitative reverse transcription PCR (qRT-PCR) to determine macaque plasma viral loads 
Viral RNA was extracted from 300 μl of plasma using the Viral Total Nucleic Acid Purification Kit 
(Promega, Madison, WI) on a Maxwell 16 MDx instrument. Viral RNA was quantified by qRT-PCR 
using the primers and probe designed by Lanciotti et al. (Lanciotti et al., 2008). The RT-PCR was 
performed using the SuperScript III Platinum one-step quantitative RT-PCR system (Invitrogen, 
Carlsbad, CA) on the LightCycler 480 instrument (Roche Diagnostics, Indianapolis, IN). Primers and 
probe were used at final concentrations of 600 nm and 100 nm, respectively, along with 150 ng random 
primers (Promega, Madison, WI). Cycling conditions were as follows: 37°C for 15 min, 50°C for 30 min 
and 95°C for 2 min, followed by 50 cycles of 95°C for 15 s and 60°C for 1 min. Virus concentration was 
determined by interpolation onto an internal standard curve composed of seven 10-fold serial dilutions of 
a synthetic ZIKV RNA fragment based on the Asian lineage. 
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Figure legends 
 
Figure 1. Workflow for the rapid prototyping of paper-based, biomolecular sensors for portable 
and low-cost diagnostics. Using sequence information from online databases, primers for isothermal 
RNA amplification and toehold switch-based RNA sensors were designed in silico using purpose-built 
algorithms. Once synthesized, the resulting sequence-specific toehold sensors can be assembled and 
validated in less than 7 hours. In under a day, validated sensors can be embedded into paper and freeze-
dried along with a cell-free transcription and translation system to be deployed in the field as stable 
diagnostics. For the diagnostic test, extracted RNA is isothermally amplified via NASBA and used to 
rehydrate the freeze-dried paper sensors. The detection of the appropriate trigger RNA is indicated by a 
color change in the paper disc from yellow to purple. 
 
Figure 2. Rapid prototyping of 48 paper-based RNA toehold sensors for Zika virus detection. 
(A) Series A toehold switch sensor schematic. The sensor design from Green et al. (2014) was modified 
with a shortened 11-nt loop sequence to reduce leakage of output gene expression. (B) Series B toehold 
switch sensor schematic. Based on the same Zika genomic region as the A series, these sensors include a 
12-nt loop and lack the refolding domain. These modifications were made to further reduce LacZ reporter 
leakage in the OFF state. (C) Maximum fold change in the rate of LacZ production for the Series A Zika 
virus RNA sensors during the first 90 min at 37C. Fold change of LacZ production rate is determined 
from the slope of absorbance at 570 nm over time (sensor alone vs. sensor with 3000 nM RNA trigger). 
Sensors are ordered according to fold change. (D) Maximum fold change in the rate of LacZ production 
for the Series B Zika virus RNA sensors during the first 90 min at 37C. Error bars represent SD from 
three replicates. Inset: average LacZ absorbance of the OFF states at 60 min indicates an overall reduction 
in LacZ reporter leakage for the Series B sensors. Error bars represent SD across the 24 sensors. See also 
Figure S1 and Table S1. 
 
Figure 3. Isothermal RNA amplification improves sensitivity of toehold switch sensors to allow for 
detection of femtomolar concentrations of Zika virus RNA fragments. (A) Sensitivity of six of the 
best performing Series A and B sensors without RNA amplification. Fold change is calculated from 
absorbance (570 nm) after 30 min at 37C. Error bars represent SD from three replicates. (B) A schematic 
of NASBA (nucleic acid sequence based amplification)-mediated RNA amplification. (C) Zika RNA 
fragments diluted in water or 7% human serum were amplified using NASBA with input concentrations 
ranging from 30 pM down to 3 fM. A 1:7 dilution of the NASBA reaction in water was then used to 
rehydrate freeze-dried, paper-based reactions containing sensors 27B and 32B. Fold change is calculated 
as described in (A) after 30 min at 37C. See also Figure S2 and Table S2. 
 
Figure 4. Moving toward a field-ready diagnostic for Zika virus. (A) Sequence-specificity of Zika 
virus sensors 27B and 32B. Sensors were challenged with 3000 nM of RNA corresponding to target 
sequences from the Zika virus or the homologous region of the Dengue virus. Fold change is calculated 
from absorbance (570 nm) at 60 min after rehydration and incubation of freeze-dried, paper-based 
reactions at 37C. Error bars represent SD from three replicates. (B) Zika virus sensors 27B and 32B were 
tested for specificity using NASBA reaction products derived from 300 fM input RNA corresponding to 
target genomic regions of the Zika or Dengue viruses in 7% human serum. Fold change was calculated as 
in (A). (C) Using the portable electronic reader, time-course data were collected for Zika virus sensor 32B 
in the presence of RNA amplified from 1 fM or 3 fM inputs of trigger RNA in 7% human serum. To 
increase sensitivity, NASBA reactions were run for 2.5 hours. Graphs plot the relative absorbance of 570 
nm wavelength light compared to background, which was collected every minute from freeze-dried, cell-
free reactions embedded into paper. (D) Incorporating viral sample processing into the diagnostic 
workflow. Lentivirus was packaged with Zika RNA or homologous Dengue RNA fragments targeted by 
sensor 32B. Three femtomolar of virus was spiked into 7% human serum and heated to 95C for 2 
minutes to extract viral RNA. The boiled lysate was used to initiate NASBA-mediated RNA 
amplification. A 1:7 dilution of the two-hour NASBA reaction in water was then used to rehydrate freeze-
dried paper-based reactions. Time-course data were collected on the portable electronic reader as in (C). 
See also Figure S3. 
 
Figure 5. NASBA-CRISPR Cleavage (NASBACC) allows for strain differentiation at a single-base 
resolution. (A) Schematic representation of NASBACC genotyping following a positive Zika diagnosis. 
A synthetic trigger sequence is appended to a NASBA-amplified RNA fragment through reverse 
transcription.  The presence of a strain-specific PAM leads to the production of either truncated or full-
length trigger RNA, which differentially activates a toehold switch (sensor H) (Pardee et al., 2014). (B) 
The probability that a non-biased single nucleotide polymorphism (SNP) between two strains can be 
discriminated by CRISPR/Cas9 is 48% (Table S4).  Hence, genetic drift between the American and 
African or Asian strains, while relatively small (14.4% and 4.9% sequence dissimilarity, respectively), 
has created hundreds of strain-specific PAM sites. (C) A SNP between African (KF268950) and 
American (KU312312) strains at site 7330 disrupts an existing PAM site, allowing for Cas9-mediated 
DNA cleavage only in the American strain. (D) Sensor 32B can distinguish between Dengue and Zika 
RNA sequences, but cannot discriminate between American and African Zika strains. Paper discs 
containing sensor 32B were rehydrated with 300 nM trigger RNA corresponding to sequences from 
American-Zika, African-Zika, or Dengue. Colorimetric outputs: a purple color indicates the activation of 
LacZ expression from the toehold switch, and a yellow color indicates the toehold switch remained 
inactive. (E) NASBACC can discriminate between American- and African-lineages of Zika virus. Paper 
discs containing sensor H were rehydrated with a 1:10 dilution of NASBACC reactions initiated with 
0.05 µl of a 300 nM RNA sample. In this case, an inactive toehold switch leads to a positive identification 
of the American Zika strain.   
 
Figure 6. Validation of diagnostic workflow on live Zika virus samples. (A) Specificity of sensor 32B 
against purified genomic RNA. Sensor 32B was tested for specificity using NASBA reaction products 
performed on 30 fM RNA purified from Zika virus and three different Dengue virus serotypes. Fold 
change is calculated from absorbance (570 nm) at 60 min after rehydration and incubation of freeze-dried, 
paper-based reactions at 37C. Error bars represent SD from three replicates.  (B) Detection of live Zika 
virus. Ten femtomolar of laboratory-cultured Zika virus was spiked into human serum (7%), heated to 
95C for 2 minutes, and used to initiate NASBA-mediated RNA amplification. A 1:7 dilution of the 
three-hour NASBA reaction in water was then used to rehydrate freeze-dried, paper-based reactions. 
Time-course data were collected on the portable electronic reader. Graph plots the relative absorbance of 
570 nm wavelength light compared to background. Error bars represent SD from three replicates. (C, D) 
Detection of Zika virus in viremic rhesus macaque plasma using sensors 27B and 32B. Plasma containing 
2.8 fM of Zika virus was diluted 1:10 in nuclease free water, heated to 95C for 2 minutes, and used to 
initiate NASBA-mediated RNA amplification. Three-hour NASBA reactions were monitored on the 
portable electronic reader as in (B). 
4 days
Visual 
Detection
Sample
Collection
RNA
Extraction
RNA
Amplification
Toehold
Reaction
7 hr 1 day
Sensor Development Stage Diagnostic Test
Design &
Synthesis Screen Manufacture
A U 
G C
2 min 2 hr 1 hr
Distribution 
& Storage
> 1 year stability
Cell-Free
System
20˚C
(5+ days) (~3 hr)
minutes
Figure1 Click here to download Figure Figure1.pdf 
C D
Switch RNA
Trigger RNA
Activated Switch
Toehold Repressed
RBS
AUG
Conserved
Sequence
Region
Active
lacZ Gene
lacZ Gene
Switch RNA
Trigger RNA
Activated Switch
Toehold Repressed 
RBS
AUG
Conserved
Sequence
Region
Refolding
Domain
Active
lacZ Gene
lacZ Gene
B Series B Zika SensorsA Series A Zika Sensors
Zika Sensors Zika Sensors
Series A Series B
Fo
ld
 C
ha
ng
e 
La
cZ
  P
ro
du
ct
io
n 
Ra
te
Fo
ld
 C
ha
ng
e 
La
cZ
 P
ro
du
ct
io
n 
Ra
te
Series A Series B
OFF level
0.00
0.02
0.04
La
cZ
 A
bs
LacZ LacZ
27 46 32 36 31 26 41 47 37 28 25 35 45 33 40 48 43 28 29 42 34 44 30 390
10
20
30
40
8 7 22 12 4 1 21 3 23 15 18 16 14 2 11 13 17 14 6 19 20 9 5 100
10
20
30
40
Figure2 Click here to download Figure Figure2.pdf 
Zika RNA
Reverse 
Transcription
RNase H 
Degradation
dsDNA
Synthesis
T7 RNA
Transcription
NASBA
(2 hr, 41°C)
primer
Toehold 
Reaction
primer
Sensor 4A
Sensor 27B 
Sensor 7A Sensor 8A
Sensor 31B Sensor 32B
Fo
ld
 C
ha
ng
e 
La
cZ
 A
bs
Zika RNA Concentration in Reaction
A
B
0
20
40
60
30
pM 3p
M
300
fM
30
fM 3 fM 0 fM
Sample Zika RNA Concentration
Fo
ld
 C
ha
ng
e 
La
cZ
 A
bs Sensor 27B Sensor 32B
Water
Serum
30
pM 3p
M
30
0 fM 30
fM 3 fM 0 fM
10-12 M 10-15 M
C
0
20
40
60
30
00
 nM
30
0 n
M
30
 nM 3 n
M
0 n
M
0
20
40
60
30
00
 nM
30
0 n
M
30
 nM 3 n
M
0 n
M
30
00
 nM
30
0 n
M
30
 nM 3 n
M
0 n
M
10-12 M 10-15 M
Figure3 Click here to download Figure
Figure3.pdf
A B
C D
95℃
2 min
NASBA
RNA
extraction
41℃
2 hr
Time (min)
0 30 60 90
0
20
40
60
80
100 32B sensor only
(+) ZIKV-lentivirus 
(+) DENV-lentivirus
Ch
an
ge
 in
 R
el
at
iv
e 
Tr
an
sm
is
si
on
 (%
)
Ch
an
ge
 in
 R
el
at
iv
e 
Tr
an
sm
is
si
on
 (%
)
Time (min)
0 30 60 90
0
25
50
75
100
32B sensor only
(+) 3 fM Zika RNA
(+) 1 fM Zika RNA
Electronic Reader Electronic Reader
RNA Input
Fo
ld
 C
ha
ng
e 
La
cZ
 A
bs
Sensor 27B Sensor 32B
0
50
100
(-) Dengue Zika(-) Dengue Zika
Fo
ld
 C
ha
ng
e 
La
cZ
 A
bs
(-) Dengue Zika
NASBA RNA Input
Sensor 27B Sensor 32B
0
50
100
(-) Dengue Zika
Viral Sample
Processing
Figure4 Click here to download Figure Figure4.pdf 
trigger H
3’ 5’
dsDNA
3’ 5’
Strain-specific PAM
Cas9+sgRNA Cas9+sgRNA
Strain A Strain B
cut
3’ 5’
3’ 5’
3’ 5’
3’ 5’
T7
trigger H* RevTrans + RNAseH degradation
2nd dna strand synthesis
RNA from NASBA
T7T7
Strain A: No toehold
               activation
Strain B: Toehold
               activation
5’ 3’
sensor H sensor H
A          NASBA-CRISPR Cleavage
KU312312 2015 Suriname (American 
                                             lineage)
KJ776791 2013 French Polynesia
JN860885 2010 Cambodia
EU545988 2007 Micronesia (Asian lineage)
KF268950 1980 
Central African Republic (African lineage)
LC002520 1947 Uganda 1559 mutations (14.4%)572 different PAM sites
530 mutations (4.90%)
136 different PAM sites
B
KU312312
(American)
KF268950
(African)
PAM site
Cas9 cut site
No Cas9 cut site
No PAM site
SNPSNP
C
NA
SB
AC
C
African
ZIKV
American
ZIKV
✘✔
American
ZIKV
37℃
2 hr
African
ZIKV
✔ ✘
NASBA
(sensor 32B)
Dengue
Virus
✘??
African 
ZIKV
American 
ZIKV
NASBACC
(sensor H)
D
E
African
ZIKV
American
ZIKV Dengue
NA
SB
A
✘??
Unknown Virus RNA
Uknown Zika Virus RNA
Figure5 Click here to download Figure
Figure5.pdf
A0 30 60 90
0
25
50
75
100 27B sensor only
(+) macaque plasma
Time (min)
Ch
an
ge
 in
 R
el
at
iv
e 
Tr
an
sm
is
si
on
 (%
)
0 30 60 90
0
25
50
75
100 32B sensor only
(+) macaque plasma
Time (min)
Ch
an
ge
 in
 R
el
at
iv
e 
Tr
an
sm
is
si
on
 (%
)
B
0 30 60 90
0
25
50
75
100 32B sensor only
(+) ZIKV
Time (min)
Ch
an
ge
 in
 R
el
at
iv
e 
Tr
an
sm
is
si
on
 (%
)
C D
se
ns
or
on
ly
De
ng
ue
1
De
ng
ue
2
De
ng
ue
4
Zik
a
0
5
10
15
20
Fo
ld
 C
ha
ng
e 
La
cZ
 A
bs
Sensor 32B
Purified Viral RNA Cultured Zika Virus
Viremic Rhesus Macaque Plasma  Viremic Rhesus Macaque Plasma
Figure6 Click here to download Figure
Figure6.pdf
Extended description for the supplemental information: 
 
In Silico Strategy for Toehold Switch Sensor and NASBA Primer Design 
We developed an integrated in silico strategy for generating optimal NASBA primers and toehold 
switches for detection of Zika. Mirroring the procedure used for running the paper-based diagnostic assay, 
we initially generated a set of optimal primers for the NASBA reaction and then developed a series of 
toehold switch designs screened for activity on the RNA transcripts produced by NASBA. 
 
Identification of Optimal NASBA Primers for Zika Amplification 
We generated a set of potential primer pairs with favorable characteristics for NASBA reactions as 
described by Deiman et al. (Deiman et al., 2002). Specifically, we analyzed the Zika genome to identify 
all potential forward and reverse priming sites that had the following characteristics: 
1.   GC content between 40-60% 
2.   Template hybridization regions of 20- to 24-nts and with DNA melting temperatures above 41°C 
3.   No consecutive runs of four or more nucleotides 
4.   An A base at the final 3’ nucleotide 
5.   Minimal DNA primer internal secondary structure, including the T7 promoter region 
6.   Minimal DNA primer dimer formation probability 
7.   Higher GC content in the 6-nts at the 5’ end of the primer that hybridized to the template 
8.   Higher AT content in the 6-nts at the 3’ end of the primer 
 
All subsequences from the Zika genome that did not satisfy requirements 1 to 4 were immediately 
eliminated from consideration. The remaining primers were then analyzed for characteristics 5-8 and the 
deviation from optimal 50% GC content, with each parameter converted into a numerical score. The 
forward NASBA primers, which append the T7 promoter site to NASBA DNA intermediate, were 
modeled with this T7 promoter site present. Accordingly, the prefix sequence 
AATTCTAATACGACTCACTATAGGGAGAAGG (T7 promoter sequence underlined) was appended 
to the 5’ end of each forward primer. The resulting scores were combined and used to estimate the overall 
favorability of every potential primer in the Zika genome. Following this initial screen, the top 2% of all 
the potential primers were then compared to the rest of the Zika genome to determine the longest 
contiguous region of the primer that matched more than one site in the genome. This comparison 
provided a coarse check of primer specificity in advance of more detailed primer specificity screening 
conducted later in the design process. The length of this contiguous region for each primer was then 
incorporated into a final score for each primer. 
 
The first stage of screening resulted in a set of forward and reverse primers to provide optimal 
characteristics for binding to the target genome; however, it did not consider other important effects on 
NASBA efficiency, namely the length and secondary structure of the amplicon produced by NASBA. To 
consider these amplicon-related effects, we first identified the binding sites for each primer on the 
genome and, if more than one primer acted at the same site, and selected the primer awarded the highest 
favorability score. We then constructed a set of potential forward and reverse primer pairs based on the 
recommended amplicon lengths for successful NASBA reactions. Although NASBA is known to work 
best with amplicons having lengths between approximately 120-nts to 250-nts (Deiman et al., 2002), our 
rapid screening approach initially employs synthetic DNA strands as templates for transcribing the target 
RNA. Since the length of these DNA oligos (IDT Ultramers) is currently limited to 200-nts including the 
T7 promoter site, we instead examined primer pairs for amplicons ranging from 120- to 176-nts in length. 
After applying all the above constraints on primer and amplicon sequences, we were left with a set of 
4351 potential NASBA primer pairs. The RNA amplicons generated for each of these primers pairs were 
then assessed for their secondary structure. NASBA reactions are known to be more effective when 
applied to templates having low secondary structure. Consequently, we examined the degree of amplicon 
single-strandedness using the NUPACK ensemble defect function (Zadeh et al., 2011a, 2011b). 
Supplemental Experimental Procedures
 
Next, each of the potential NASBA primers were then coarsely screened for sequence similarities with 11 
viruses known to be closely related to Zika: Dengue virus 1, Dengue virus 2, Dengue virus 3, Dengue 
virus 4, West Nile virus, St. Louis encephalitis virus, yellow fever virus, Powassan virus, Semliki Forest 
virus, O'nyong'nyong virus, and Chikungunya virus. Sequence similarities were estimated by determining 
the maximum contiguous sequence in the primer that was found in any of the 11 related viruses. More 
stringent specificity screening was carried out in later stages as described below. 
 
After all the above screening procedures, the final NASBA primer pairs were sorted by quality after 
taking into account the favorability scores of each primer, the secondary structure of the amplicon, and 
the potential for non-specific binding with other viruses. 
 
Identification of Optimal Toehold Switches for NASBA Products 
Out of the 4351 NASBA amplicons, we selected the top 1025 as potential targets for toehold switches. 
The in silico design process for these toehold switches followed closely that previously used for designing 
mRNA sensors in vivo (Green et al., 2014) and on paper (Pardee et al., 2014). Briefly, we designed 
toehold switch mRNA sensors that hybridized to the NASBA amplicon at 1-nt increments. This sliding 
window encompassed the internal region of the NASBA product outside of the primer binding sites. This 
internal region was selected to avoid any potential for sensor activation or competitive binding by residual 
NASBA primers. The resulting toehold switches were analyzed for secondary structure and toehold 
availability, and screened to eliminate any sensors with unwanted in-frame stop codons in the output gene 
sequence. The target transcript itself was again assayed for single-strandedness and availability of the 
sensor binding sites. The above factors were incorporated into a sensor design score as described 
previously (Green et al., 2014). The highest scoring toehold switch sensor for each amplicon was then 
passed on to the final selection stage. 
 
Final Design Selection Process 
After the above screening and design stages, we assembled the set of 1025 NASBA primer pairs with 
corresponding optimized toehold switch sensors. The top overall designs were selected by combining the 
favorability scores obtained from the NASBA and toehold switch evaluation steps. The primer and sensor 
sequences from these top designs were then tested for specificity against the human transcriptome and the 
same panel of closely related viral genomes listed above using NCBI/Primer-BLAST. Moreover, they 
were screened for specificity within the Zika genome itself. Ultimately, the top 24 designs that survived 
the Primer-BLAST specificity stage were selected for testing using our rapid in vitro screening approach. 
 
Modifying the Toehold Switch Sensor Design for Decreased Signal Leakage 
Detailed studies of the toehold switch design parameters (Green et al., 2014) and thermodynamic 
considerations suggested two simple strategies for decreasing leakage from the toehold switches: reducing 
the size of the loop containing the ribosome binding site (RBS) in the sensor, and further stabilization of 
the sensor stem. We applied both these strategies in the Zika-specific toehold switches. 
 
We have previously found that the ON and OFF state signals from the toehold switches increase as the 
size of the loop in the switch RNA increases. This effect is likely due to two factors: increased 
accessibility of the RBS to the ribosome, which promotes translation in the presence or absence of the 
target RNA; and entropic effects that discourage stem formation as the loop becomes longer. Conversely, 
decreasing the size of the loop is associated with lower leakage, albeit with a decrease in ON state 
activity. Stabilizing the switch RNA stem by adding additional base pairs or by eliminating the 
downstream refolding domain (Green et al., 2014) increases the free energy required to unwind the sensor 
stem and thus encourages decreased signal leakage. 
 
In accordance with above factors, we tested two different types of toehold switches aiming to lower 
leakage. The first type of sensor, referred to as the A series, are nearly identical to those previously used 
for mRNA sensing (Green et al., 2014; Pardee et al., 2014), except their loop domain has been reduced 
from 18-nts to 11-nts. These A sensors retained the downstream refolding domain to encourage sensor 
triggering and they all have the same sequence at the top of the sensor stem-loop 
(GUUAUAGUUAUGAACAGAGGAGACAUAACAUGAAC) as illustrated in Figure 2A. 
 
The second type of sensor, referred to as the B series, possesses a stem that has been lengthened by one 
base pair overall and a loop region that is only 12-nts. Importantly, the B sensors also lack the 
downstream refolding domain to further stabilize the OFF state. The parental toehold switch for the B 
sensors exhibited extremely low leakage in preliminary measurements in paper-based reactions and 
provided a sizeable ON/OFF ratio of ~600-fold regulating GFP expression in E. coli. These B sensors all 
featured the same conserved sequence (GGACUUUAGAACAGAGGAGAUAAAGAUG) at the top of 
their stem-loops as illustrated in Figure 2B. 
 
 
Considerations of Sequence Information in Design of the Biomolecular Diagnostics 
 
Evolutionary drift 
At the time we began our experiments, few complete genomes for the Zika virus had been reported. In 
fact, the first complete genome of the strain circulating in the Americas was only published on January 7 
in The Lancet (Enfissi et al., 2016). However, previous comparisons of Zika strains do provide 
information on the degree of evolutionary drift for the virus. Haddow et al. found that a Zika strain 
isolated in Malaysia in 1966 differed by only 4.3% in nucleotide sequence from isolates obtained 
Micronesia and Cambodia in 2007 and 2010, respectively (Haddow et al., 2012). Authors also found 
≤11.7% nucleotide sequence difference between African and Asian virus lineages, which they argued 
provided sufficient conserved sequence for genetic tests for both lineages. More recent studies have 
shown the rate of mutation of Zika is ~10-3 nucleotide changes/site/year, which is relatively high among 
flaviviruses, but a manageable rate for our diagnostic assay (Faria et al., 2016). 
 
Specificity of the NASBA/toehold switch isothermal assay 
Since our experiments are performed at mostly 41°C and 37°C, melting-temperature-dependent tuning of 
primer specificity is not possible in our assays. The benefit of this temperature limitation is that our 
NASBA and toehold switch detection schemes are able to tolerate mismatches and compensate for 
variability in the sequence of the target RNA molecules. We have analyzed the binding between the 
toehold switch 32B, our highest performing sensor, and RNAs from homologous regions in Zika strains 
isolated from Africa (Uganda, Nigeria, Senegal) and Asia (Malaysia, Cambodia, French Polynesia). All 
these strains are predicted to fully activate the toehold sensors even with up to 4-nt (11%) mismatches.  
 
Compensating for evolutionary drift 
The above analysis is borne out in data showing that sensor 32B can detect the target sequence from both 
the American and African strains of the virus (Figure 5E). This flexibility in sequence detection is 
balanced with the three combined layers of specificity in our biomolecular approach.  This includes the 
extensive in silico screening of NASBA primers and toehold switch sequences to limit cross-reactivity 
with off-target sequences and the single-base discrimination of NASBACC. The net result is a 
programmable platform that can be manufactured to produce diagnostics with both high sequence 
specificity and the capacity to manage sequence diversity as pathogens evolve. It is also worth mentioning 
that, in addition to increasing specificity, NASBACC can be used to remove non-specific sequences from 
samples as well as aid in the discovery mutations in the target regions. 
 
Integration with signature erosion analysis tools 
In the future, we plan to integrate existing tools for identifying optimal primer sites for sequence-specific 
detection into our toehold switch/NASBA primer design algorithms. Software such as BioVelocity 
(Sozhamannan et al., 2015) and TOPSI (Vijaya Satya et al., 2010) are adept at determining conserved 
sequence regions across multiple genomes and eliminating those shared with other pathogens or humans. 
Using these valuable tools, we can rapidly generate a set of specific sites for NASBA priming and toehold 
switch binding. We can then subject these carefully selected regions to the same screening by toehold 
secondary structure and NASBA primer characteristics described in this work. 
 
Freeze-dried NASBA 
For freeze-dried NASBA experiments, Enzyme Mix was lyophilized separately from the other 
components. The solution containing reaction buffer, nucleotide mix, RNase inhibitor, and primers was 
reconstituted in 15% DMSO, while the Enzyme Mix was reconstituted in nuclease-free water. Once 
reconstituted, the experiments proceeded as described in the Experimental Procedures section. 
 
Freeze-dried CRISPR/Cas9 nuclease assay 
Reactions were performed in a 30 µl volume of 1x Cas9 Nuclease Reaction Buffer (NEB #M0386S) 
containing 30 nM of guide RNA (gRNA), 30nM of Cas9 Nuclease (S. pyogenes, NEB #M0386S), and 3 
nM of substrate DNA (pAG_TS1_KS001 plasmid). Six gRNA sequences targeting the lacZ gene 
(Doench et al., 2014) inserted into plasmid pAG_TS1_KS001 were used for the CRISPR/Cas9 freeze-
dried assay (Figure S5A). All components except substrate DNA were first combined in a 27 µl reaction 
volume and incubated for 10 minutes at 25°C to allow Cas9+gRNA to form duplexes. For fresh reactions, 
3 µl of a 30 nM solution of substrate DNA was added to the solution. For freeze-dried reactions, the 27 µl 
solution was lyophilized overnight and reconstituted with 30 µl of a solution containing 3 nM of substrate 
DNA. After the addition of substrate DNA, the solution was incubated for 1 h at 37°C and run on a 1% 
agarose gel for fragment analysis (Figure S5B).  
 
Care and use of macaques at the Wisconsin National Primate Research Center 
All Indian-origin rhesus macaque monkeys from which plasma was isolated were cared for by the staff at 
the Wisconsin National Primate Research Center (WNPRC) in accordance with the regulations and 
guidelines outlined in the Animal Welfare Act and the Guide for the Care and Use of Laboratory Animals 
and the recommendations of the Weatherall report. This study was approved by the University of 
Wisconsin-Madison Graduate School Institutional Animal Care and Use Committee (Animal Care and 
Use Protocol Number G005401). For all procedures (i.e., physical examination, virus inoculation, blood 
and swab collection), animals were anesthetized with an intramuscular dose of ketamine (10 ml/kg).  
Blood samples were obtained using a vacutainer system or needle and syringe from the femoral or 
saphenous vein.   
 
Zika virus stock production for macaque infection 
ZIKV strain H/PF/2013 (GenBank accession number: KJ776791), originally isolated from a 51-year-old 
female in France returning from French Polynesia with a single round of amplification on Vero cells, was 
obtained from Xavier de Lamballerie (European Virus Archive, Marseille France). Virus stocks were 
prepared by inoculation onto a confluent monolayer of C6/36 mosquito cells. A single harvest of virus 
with a titer of 1.26 x 106 PFU/ml for the Asian-lineage (equivalent to 1.43 x 109 vRNA copies/ml) was 
used.  
 
Zika virus challenge of macaques, plasma collection and processing 
The virus stock was thawed, diluted in PBS to the appropriate concentration for each challenge, and 
loaded into a 1 ml syringe that was kept on ice until challenge. Animals were anesthetized as described 
above, and 1 ml of inocula was administered subcutaneously over the cranial dorsum. At the conclusion 
of the procedure, animals were closely monitored by veterinary and animal care staff for adverse reactions 
and signs of disease. Fresh plasma and PBMC were isolated from EDTA-treated whole blood by Ficoll 
density centrifugation at 1860 rcf for 30 min. The plasma layer was collected and centrifuged for an 
additional 8 min at 670 rcf to remove residual cells. The supernatant plasma was then filtered over a 0.45 
µm syringe filter. Collected plasma was diluted 1:10 in nuclease free water. Diluted samples were heated 
to 95°C for two minutes and immediately added to a NASBA reaction as described above. NASBA was 
run for three hours.  
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Figure S1. Results of Zika virus sensor screening (Related to Figure 2). Using low-volume paper-based 
reactions +/- 3000 nM RNA (36 nt) corresponding to the targeted Zika virus genomic RNA sequence of each 
sensor. Data represent absorbance at 570 nm plotted over time. 
 
Figure S2. Sensor specificity and sensitivity (Related to Figure 3). (A) Linear response of sensors 27B, 31B 
and 32B to corresponding RNA trigger at 0 nM, 3 nM, 30 nM and 300 nM. Each point represents the mean of 
triplicate data taken at 60 min. (B) Orthogonality of sensors 27B, 7A and 32B to treatments of 3000 nM of 
trigger RNA from each of the three sensors. The absorbance output (570 nm) of the sensors at each time point 
was converted to a ratio of the maximum absorbance of respective sensor at the 90-min time point and plotted 
as a heat map. Yellow indicates no sensor activation and purple indicates maximum sensor activation. (C) 
Reproducibility of NASBA reactions. Samples of Zika RNA in water or 7% human serum were amplified in 
three independent 2-hour NASBA reactions. Each NASBA reaction was diluted 1:7 in water and used to 
rehydrate three freeze-dried, paper-based reactions containing sensor 27B for a total of nine replicates. Fold 
change was calculated from absorbance (570 nm) after 30 min at 37°C. Error bars represent SD from nine 
replicates for the 3 pM sample and three replicates for the 0 pM sample. (D) Effect of NASBA reaction time 
on sensitivity. Samples of Zika RNA in 7% human serum were amplified in NASBA reactions for 30, 60, and 
90 min. Diluted NASBA reactions (1:7) were tested with sensor 32B. Fold change was calculated as above. 
Error bars represent SD of three replicates. (E) NASBA with freeze-dried reagents. Samples of Zika RNA in 
7% human serum were amplified by NASBA reagents in the standard formulation and by reagents freeze-dried 
in-house. Fold change and error bars were calculated as above after 60 min. (F) Removing the 65°C step from 
NASBA protocol. Samples of Zika RNA in 7% human serum incubated at 95°C for two minutes, mimicking 
viral lysis, and then amplified by NASBA according to the standard procedure without the 65°C step. Fold 
change and error bars were calculated as above after 60 min. 
 
Figure S3. Sequence alignments and RNA extraction optimization (Related to Figure 4). Sequence 
alignments of Zika virus and Dengue virus genomic regions targeted by sensors (A) 27B and (B) 32B. Red 
boxes indicates sequences targeted by the respective toehold switches, red and blue boxes indicate the 
NASBA-amplified regions, and the remaining sequence indicates natural flanking RNA sequences from each 
virus. The entire Zika 32 sequence shown here was cloned into lentivirus to make proxy Zika virus. (C) Effect 
of boiling time on RNA extraction. Lentivirus was packaged with the Zika virus RNA fragment corresponding 
to sensor 32B. Virus was diluted to 10 and 3 fM target RNA in 7% human serum. Twenty-five µL of virus was 
heated to 95C for 1 and 2 minutes. One µL was then used to initiate NASBA-mediated RNA amplification. A 
1:7 dilution of 2 hour NASBA reactions in water was then used to rehydrate freeze-dried, paper-based 
reactions. Fold change was calculated from absorbance (570 nm) after 60 min at 37C. Error bars represent SD 
of three replicates. 
 
Figure S4. Portable electronic optical reader (Related to Figure 4). (A) Line drawings used to cut the 
housing for the electronic reader from black acrylic using a laser cutter. (B) Image of the 16-reaction reader 
from the front. Chip containing paper-based sensors slides into the slot illuminated by the green light. Reader 
dimensions: 106 mm wide x 116 mm deep x 96 mm high. (C) Components and circuit design used to assemble 
the electronic optical reader. 
 
Figure S5. CRISPR nuclease assay using fresh and freeze-dried reactions (Related to Figure 5). (A) 
Sequence information and location of the gRNA used to target the LacZ gene. Each sequence was selected for 
maximum activity using the Doench et al. scoring algorithm (Doench et al., 2014)  (B) Gel showing the length 
of supercoiled vs. cut DNA following the in vitro digestion of a LacZ-containing plasmid for fresh and freeze-
dried reactions. Note that the activity of some gRNA/Cas9 combinations is improved under freeze-dried 
conditions. 
 
Table S1. Sequences of Toehold Switch Sensors and Corresponding Target Sequences in Zika Genome 
(related to Figure 2 and Figure S1). 
 
Supplemental Legends
Table S2. Sequences of NASBA Primers Used for Zika RNA Amplication (related to Figure 3 and 
Figure S2). 
 
Table S3. Portable electronic reader build of materials (related to Figure 4 and Figure S4). 
 
Table S4. Probabilities of PAM site disruption from single point mutations (Related to Figure 5 and 
Figure S5). 
 
 
Table S1. Sequences of Toehold Switch Sensors and Corresponding Target Sequences in Zika Genome (related to Figure 2 and Figure S1)
NOTES:
1. The sequence GGG was added to the 5' end of all sensor RNA and target RNA fragment sequences for efficient expression by T7 RNA polymerase. If the RNA sequence began with G or GG, only GG or G, respectively, was added to the 5' end of the sequence.
2. The GGG prefix is not shown in the sensor sequences in the table so that the target RNA binding site can be readily identified.
3. The coding sequence of the reporter protein lacZ was added immediately after the switch RNA sequences in the tables.
4. Two Zika virus strains (KU312312, AY632535) have sufficient sequence homology to be detected using the same toehold switch sensors (27B, 32B).
5. Target RNAs fragments for sensors 7A/31B and 11A/35B have a GGGAGAAGG sequence added at the 5' end.
6. Target RNA fragments for sensors 12A/36B have a GGGAGAAG sequence added at the 5' end.
Target sequence in Zika virus genome Sensor Name
UUGAGAGUGAGAAGAAUGACACAUGGAGGCUGAAGA 3027 1A
AUGAUGGGAAAAAGAGAAAAGAAACAAGGGGAAUUU 8963 2A
GACACAGGACAUGAAACUGAUGAGAAUAGAGCGAAA 1373 3A
UGGAAAACAUCAUGUGGAGAUCAGUAGAAGGGGAGC 2610 4A
GGGGAAAAAAGAGGCUAUGGAAAUAAUAAAGAAGUU 256 5A
GAUAACGCCCAAUUCACCAAGAGCCGAAGCCACCCU 1414 6A
UUGAAGAGGAAAAAGAGUGGAAGACUGCAGUGGAAG 8841 7A
UUUUGCUCGUGGCGCACUACAUGUACUUGAUCCCAG 7188 8A
UUGCUACUCACAAUUAACACCCCUGACCCUAAUAGU 7144 9A
ACCACCUCAUACAACAACUACUCCUUAAUGGCGAUG 7022 10A
ACCACAAAGAUCAUCAUAAGCACAUCAAUGGCAGUG 3563 11A
AGACAGAGUUCCAGAAAACAAAACAUCAAGAGUGGG 5721 12A
UGCACAAUGCCCCCACUGUCGUUCCGGGCUAAAGAU 3368 13A
GACACCGGAACUCCACACUGGAACAACAAAGAAGCA 1598 14A
GUUUGCCGCUGGGAAAAGAGGAGCGGCUUUUGGAGU 6379 15A
GGCAGAAGUGUGGACCAGACACGGAGAGAAAAGAGU 6277 16A
CUGAUCGAGAUGAAAACAUGUGAAUGGCCAAAGUCC 3071 17A
GAGCCAGAAAAGCAAAGAUCUCCCCAGGACAACCAA 6761 18A
CUUAACACAUUUACCAACCUAGUGGUGCAACUCAUU 9431 19A
GCGGUACAGGGGUGUUCGUCUAUAACGACGUUGAAG 2466 20A
GAGGCUGAGGAAGUUCUAGAGAUGCAAGACUUGUGG 9476 21A
GGCACAGUGAAGAGCUUGAAAUUCGGUUUGAGGAAU 3225 22A
CAUCUAAUGGGAAGGAGAGAGGAGGGGGCAACCAUA 6890 23A
GAUAGGUUUGCACAUGCCCUCAGGUUCUUGAAUGAU 9620 24A
Zika virus from the Americas genome sequence (Accession 
number: KU312312; 10,374-nts)
Location in 
genome
A Series Sensors
ACAGGUUUUAUUUUGGAUUUGGAAACGAGAGUUUCUGG
UCAUGAAAAACCCAAAAAAGAAAUCCGGAGGAUUCCGGA
UUGUCAAUAUGCUAAAACGCGGAGUAGCCCGUGUGAGC
CCCUUUGGGGGCUUGAAGAGGCUGCCAGCCGGACUUCU
GCUGGGUCAUGGGCCCAUCAGGAUGGUCUUGGCGAUUC
UAGCCUUUUUGAGAUUCACGGCAAUCAAGCCAUCACUGG
GUCUCAUCAAUAGAUGGGGUUCAGUGGGGAAAAAAGAG
GCUAUGGAAAUAAUAAAGAAGUUCAAGAAAGAUCUGGCU
GCCAUGCUGAGAAUAAUCAAUGCUAGGAAGGAGAAGAAG
AGACGAGGCGCAGAUACUAGUGUCGGAAUUGUUGGCCU
CCUGCUGACCACAGCUAUGGCAGCGGAGGUCACUAGAC
GUGGGAGUGCAUACUAUAUGUACUUGGACAGAAACGAUG
CUGGGGAGGCCAUAUCUUUUCCAACCACAUUGGGGAUG
Table S1
MR 766 Zika virus genome, Uganda 1947 (Accession 
number: AY632535; 10,794-nts)
AGUUGUUGAUCUGUGUGAGUCAGACUGCGACAGUUCGA
GUCUGAAGCGAGAGCUAACAACAGUAUCAACAGGUUUAA
UUUGGAUUUGGAAACGAGAGUUUCUGGUCAUGAAAAACC
CCAAAGAAGAAAUCCGGAGGAUCCGGAUUGUCAAUAUGC
UAAAACGCGGAGUAGCCCGUGUAAACCCCUUGGGAGGU
UUGAAGAGGUUGCCAGCCGGACUUCUGCUGGGUCAUGG
ACCCAUCAGAAUGGUUUUGGCGAUACUAGCCUUUUUGAG
AUUUACAGCAAUCAAGCCAUCACUGGGCCUUAUCAACAG
AUGGGGUUCCGUGGGGAAAAAAGAGGCUAUGGAAAUAAU
AAAGAAGUUCAAGAAAGAUCUUGCUGCCAUGUUGAGAAU
AAUCAAUGCUAGGAAAGAGAGGAAGAGACGUGGCGCAGA
CACCAGCAUCGGAAUCAUUGGCCUCCUGCUGACUACAGC
CAUGGCAGCAGAGAUCACUAGACGCGGGAGUGCAUACUA
Table S1. Sequences of Toehold Switch Sensors and Corresponding Target Sequences in Zika Genome (related to Figure 2 and Figure S1)
1. The sequence GGG was added to the 5' end of all sensor RNA and target RNA fragment sequences for efficient expression by T7 RNA polymerase. If the RNA sequence began with G or GG, only GG or G, respectively, was added to the 5' end of the sequence.
2. The GGG prefix is not shown in the sensor sequences in the table so that the target RNA binding site can be readily identified.
3. The coding sequence of the reporter protein lacZ was added immediately after the switch RNA sequences in the tables.
4. Two Zika virus strains (KU312312, AY632535) have sufficient sequence homology to be detected using the same toehold switch sensors (27B, 32B).
5. Target RNAs fragments for sensors 7A/31B and 11A/35B have a GGGAGAAGG sequence added at the 5' end.
6. Target RNA fragments for sensors 12A/36B have a GGGAGAAG sequence added at the 5' end.
Sensor sequence Sensor Name Sensor sequence
UCUUCAGCCUCCAUGUGUCAUUCUUCUCACUCUCAAGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACUUGAGAAACCAAGUUAACCUGGCGGCAGCGCAAAAG25B UCUUCAGCCUCCAUGUGU UUCUUCU CUCUCAAGGAC UUAG AG GAG UAAA AU UU A AGUG UAACCUGGCGGCAGCGCAAAAG
AAAUUCCCCUUGUUUCUUUUCUCUUUUUCCCAUCAUGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACAUGAUGAACCAUGUUAACCUGGCGGCAGCGCAAAAG26B AAAUUCCCCUUGUUUCUUUUCUCUUUUUCCC UCAUGGAC UUA AGA GAG UAAA AU AU AUGGG AAAACCUGGCGGCAGCGCAAAAG
UUUCGCUCUAUUCUCAUCAGUUUCAUGUCCUGUGUCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGACACAAACGUCGUUAACCUGGCGGCAGCGCAAAAG27B UUUCGC CUAUUC CAUC GUUUCAU UCCUGUG CGGACUUUAG AGA GAG UAAA AU G CACAGG CACAACCUGGCGGCAGCGCAAAAG
GCUCCCCUUCUACUGAUCUCCACAUGAUGUUUUCCAGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACUGGAAAAACCCAGUUAACCUGGCGGCAGCGCAAAAG28B GCUCCCCUUCUACUGAUCUCC CAUGAUG UUUCCAGGACUUU G AG GAG UAAA AU UG AAAAC UCAAACCUGGCGGCAGCGCAAAAG
AACUUCUUUAUUAUUUCCAUAGCCUCUUUUUUCCCCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGGGGAAAACCCCGUUAACCUGGCGGCAGCGCAAAAG29B AACUUCUUUAUUAUUUCCAUAGCCUCUUUUUU CCCGGACUUU G AGA GAG UAAAGAUGGG GAAAAAAGAAACCUGGCGGCAGCGCAAAAG
AGGGUGGCUUCGGCUCUUGGUGAAUUGGGCGUUAUCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGAUAACAACAUCGUUAACCUGGCGGCAGCGCAAAAG30B AGGGU GCU C GCUCUUGGUGAAUU GGCGUU CGGACU U G GA GAGAUAAA AU G UAACGCCCAUAACCUGGCGGCAGCGCAAAAG
CUUCCACUGCAGUCUUCCACUCUUUUUCCUCUUCAAGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACUUGAAGAACCAAGUUAACCUGGCGGCAGCGCAAAAG31B CUUCCACUGCAGUC UCCACUCUUUUU C CUUCAAGGAC UU AG GAG UAAA AU UU AAG GG AAAACCUGGCGGCAGCGCAAAAG
CUGGGAUCAAGUACAUGUAGUGCGCCACGAGCAAAAGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACUUUUGCAACAAAGUUAACCUGGCGGCAGCGCAAAAG32B UGG AUCAAGUACAUGUAGUGC CC GAGCA AAGGAC AG G GAG UAAA AU UUUU UCGU UAACCUGGCGGCAGCGCAAAAG
ACUAUUAGGGUCAGGGGUGUUAAUUGUGAGUAGCAAGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACUUGCUAAACCAAGUUAACCUGGCGGCAGCGCAAAAG33B CU UUAGGGUCAGGGGUGUU AUUGUG GU GCAAGGAC UUAG AG GAG UAAA AU UU UACUC CUAACCUGGCGGCAGCGCAAAAG
CAUCGCCAUUAAGGAGUAGUUGUUGUAUGAGGUGGUGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACACCACCAACGGUGUUAACCUGGCGGCAGCGCAAAAG34B CAUCGCCAU AGG GU GUU UU UAUG GGUGGUGGACUUUAG A A GAG UAAA AUGACCACCUCAUAUAACCUGGCGGCAGCGCAAAAG
CACUGCCAUUGAUGUGCUUAUGAUGAUCUUUGUGGUGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACACCACAAACGGUGUUAACCUGGCGGCAGCGCAAAAG35B CACUGCCAU GA GUGCUUAUGAU UCUUUGUGGUGGACUUUAG A A GAG UAAA AU ACCACAA GAUAAACCUGGCGGCAGCGCAAAAG
CCCACUCUUGAUGUUUUGUUUUCUGGAACUCUGUCUGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACAGACAGAACUCUGUUAACCUGGCGGCAGCGCAAAAG36B CCCACUC UG UG U UGUUUUCUGGAACUCUGUCUGGACUUU AGA GAG UAAA AU AGACAGAGUUCCAACCUGGCGGCAGCGCAAAAG
AUCUUUAGCCCGGAACGACAGUGGGGGCAUUGUGCAGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACUGCACAAACGCAGUUAACCUGGCGGCAGCGCAAAAG37B A CUUUAGCCC GA C CAGUG GGCAUUGUGCAGGACUUUAG AG GAG UAAA AU UGCACAAUGCCGAACCUGGCGGCAGCGCAAAAG
UGCUUCUUUGUUGUUCCAGUGUGGAGUUCCGGUGUCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGACACCAACGUCGUUAACCUGGCGGCAGCGCAAAAG38B UGC UCUUUGUUG UCC GUGUG AGUU CGGUG CGGACUUUAG AGA GAG UAAA AUGG CACCGG CAAACCUGGCGGCAGCGCAAAAG
ACUCCAAAAGCCGCUCCUCUUUUCCCAGCGGCAAACGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGUUUGCAACAACGUUAACCUGGCGGCAGCGCAAAAG39B ACUCCAAA GCCGCUCCUCUUUUCCCAGCGGCA ACGGAC AG GA GAG UAAA AUGGUUU CGCU CAACCUGGCGGCAGCGCAAAAG
ACUCUUUUCUCUCCGUGUCUGGUCCACACUUCUGCCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGGCAGAAACGCCGUUAACCUGGCGGCAGCGCAAAAG40B ACU UU C CUCCG UCUGGUCCACACUUCUGCCGGACUUUAG AGA GAG UAAAGAUGGGCAGAAGUGUAAACCUGGCGGCAGCGCAAAAG
GGACUUUGGCCAUUCACAUGUUUUCAUCUCGAUCAGGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACCUGAUCAACCAGGUUAACCUGGCGGCAGCGCAAAAG41B GGACUUUGGCCAUUCACAUGUUUUCAUCUCG UCA GGA UUAG AGA GAG UAAA AUGCU AUCG G UGAACCUGGCGGCAGCGCAAAAG
UUGGUUGUCCUGGGGAGAUCUUUGCUUUUCUGGCUCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGAGCCAAACCUCGUUAACCUGGCGGCAGCGCAAAAG42B UUGGUUG CCU GGGA U UUUGCUUUUCUGGC CGGACUUUAG AGA GAG UAAA AUGG CAG AGAACCUGGCGGCAGCGCAAAAG
AAUGAGUUGCACCACUAGGUUGGUAAAUGUGUUAAGGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACCUUAACAACAAGGUUAACCUGGCGGCAGCGCAAAAG43B AAUGA GCACCACUAGGUUG UAAAUGUGUU A GGA U G GA GAGAUAAA AU UUAACAC UUGAACCUGGCGGCAGCGCAAAAG
CUUCAACGUCGUUAUAGACGAACACCCCUGUACCGCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGCGGUAAACCGCGUUAACCUGGCGGCAGCGCAAAAG44B UUCAACGUCGUUAUAGACGAACACCCCUGU CGCGGACUUUAG A A GAG UAAAGAUGGCGGUACAGG AAACCUGGCGGCAGCGCAAAAG
CCACAAGUCUUGCAUCUCUAGAACUUCCUCAGCCUCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGAGGCUAACCUCGUUAACCUGGCGGCAGCGCAAAAG45B ACAAGUCUUGCAUCUCU ACUUCCUCAG C CGGACUUUAG AGA GAG UAAAGAUGGAGGCUG GGACAACCUGGCGGCAGCGCAAAAG
AUUCCUCAAACCGAAUUUCAAGCUCUUCACUGUGCCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGGCACAAACGCCGUUAACCUGGCGGCAGCGCAAAAG46B AUU CUCAAACCGAAUUUCAAGCUCUUCACUGUGCCGGACUUUAG AGA GAG UAAA AUGGGCACAGUG AAAACCUGGCGGCAGCGCAAAAG
UAUGGUUGCCCCCUCCUCUCUCCUUCCCAUUAGAUGGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACCAUCUAAACAUGGUUAACCUGGCGGCAGCGCAAAAG47B UAUGGU GCCCCCUCCUCUCUCCUUCCCAUU G GGA U UAG GA GAG UAAA AU U UAAUGG AAACCUGGCGGCAGCGCAAAAG
AUCAUUCAAGAACCUGAGGGCAUGUGCAAACCUAUCGUUAUAGUUAUGAACAGAGGAGACAUAACAUGAACGAUAGGAACAUCGUUAACCUGGCGGCAGCGCAAAAG48B AUCAUUCAAGAACCUGAGGGC U U CA ACCU CGGACU UA GA GAG UAAA AUGG UAGGUUUGCUAACCUGGCGGCAGCGCAAAAG
A Series Sensors B Series Sensors
ACAGGUUUUAUUUUGGAUUUGGAAACGAGAGUUUCUGG
UCAUGAAAAACCCAAAAAAGAAAUCCGGAGGAUUCCGGA
UUGUCAAUAUGCUAAAACGCGGAGUAGCCCGUGUGAGC
CCCUUUGGGGGCUUGAAGAGGCUGCCAGCCGGACUUCU
GCUGGGUCAUGGGCCCAUCAGGAUGGUCUUGGCGAUUC
UAGCCUUUUUGAGAUUCACGGCAAUCAAGCCAUCACUGG
GUCUCAUCAAUAGAUGGGGUUCAGUGGGGAAAAAAGAG
GCUAUGGAAAUAAUAAAGAAGUUCAAGAAAGAUCUGGCU
GCCAUGCUGAGAAUAAUCAAUGCUAGGAAGGAGAAGAAG
AGACGAGGCGCAGAUACUAGUGUCGGAAUUGUUGGCCU
CCUGCUGACCACAGCUAUGGCAGCGGAGGUCACUAGAC
GUGGGAGUGCAUACUAUAUGUACUUGGACAGAAACGAUG
CUGGGGAGGCCAUAUCUUUUCCAACCACAUUGGGGAUG
AGUUGUUGAUCUGUGUGAGUCAGACUGCGACAGUUCGA
GUCUGAAGCGAGAGCUAACAACAGUAUCAACAGGUUUAA
UUUGGAUUUGGAAACGAGAGUUUCUGGUCAUGAAAAACC
CCAAAGAAGAAAUCCGGAGGAUCCGGAUUGUCAAUAUGC
UAAAACGCGGAGUAGCCCGUGUAAACCCCUUGGGAGGU
UUGAAGAGGUUGCCAGCCGGACUUCUGCUGGGUCAUGG
ACCCAUCAGAAUGGUUUUGGCGAUACUAGCCUUUUUGAG
AUUUACAGCAAUCAAGCCAUCACUGGGCCUUAUCAACAG
AUGGGGUUCCGUGGGGAAAAAAGAGGCUAUGGAAAUAAU
AAAGAAGUUCAAGAAAGAUCUUGCUGCCAUGUUGAGAAU
AAUCAAUGCUAGGAAAGAGAGGAAGAGACGUGGCGCAGA
CACCAGCAUCGGAAUCAUUGGCCUCCUGCUGACUACAGC
CAUGGCAGCAGAGAUCACUAGACGCGGGAGUGCAUACUA
1. The sequence GGG was added to the 5' end of all sensor RNA and target RNA fragment sequences for efficient expression by T7 RNA polymerase. If the RNA sequence began with G or GG, only GG or G, respectively, was added to the 5' end of the sequence.
Sequence Genome Start site Genome End site Genome fragment length
GGGCAGUGAUCUAGGCUACUGGAUUGAGAGUGAGAAGAAUGACACAUGGAGGCUGAAGAGGGCCCAUCUGAUCGAGAUGAAAACAUGUGAAUGGCCAAAGUCCCACACAUUGUGGACAGAUGGAAUAGAAGAGAGUGAUCUGAUCAUACCCAAGUCUUUAGCUGGGC3007 3170 164
GGGUGCCAGAGUUGUGUGUACAACAUGAUGGGAAAAAGAGAAAAGAAACAAGGGGAAUUUGGAAAGGCCAAGGGCAGCCGCGCCAUCUGGUAUAUGUGGCUAGGGGCUAGAUUUCUAGAGUUCGAAGCCCUUGGAUUCUUGAACGAGGAUCACUGGAUGG8941 9098 158
GGGCCAGCACAGUGGGAUGAUCGUUAAUGACACAGGACAUGAAACUGAUGAGAAUAGAGCGAAAGUUGAGAUAACGCCCAAUUCACCAAGAGCCGAAGCCACCCUGGGGGGGUUUGGAAGCCUAGGACUUGAUUGUGAACCGAGGACAGG1348 1494 147
GGGCGGGAUCUCCUCUGUUUCAAGAAUGGAAAACAUCAUGUGGAGAUCAGUAGAAGGGGAGCUCAACGCAAUCCUGGAAGAGAAUGGAGUUCAACUGACGGUCGUUGUGGGAUCUGUAAAAAACCCCAUGUGGAGAGGUCCACAGAGAUU2586 2733 148
GGGCCAUCACUGGGUCUCAUCAAUAGAUGGGGUUCAGUGGGGAAAAAAGAGGCUAUGGAAAUAAUAAAGAAGUUCAAGAAAGAUCUGGCUGCCAUGCUGAGAAUAAUCAAUGCUAGGAAGGAGAAGAAGAGACGAGGCGCAGAUACUAGUGUCGGAAUUGUUGGCCUC220 385 166
GGGAAUGCUGUCAGUUCAUGGCUCCCAGCACAGUGGGAUGAUCGUUAAUGACACAGGACAUGAAACUGAUGAGAAUAGAGCGAAAGUUGAGAUAACGCCCAAUUCACCAAGAGCCGAAGCCACCCUGGGGGGGUUUGGAAGCCUAGGACUUGAUUGUGAACCGAGGACAGG1327 1494 168
GGGAGAAGGAUGGUCUCUUCCUGGUUGUGGAAAGAGCUAGGCAAACACAAACGGCCACGAGUCUGUACCAAAGAAGAGUUCAUCAACAAGGUUCGUAGCAAUGCAGCAUUAGGGGCAAUAUUUGAAGAGGAAAAAGAGUGGAAGACUGCAGUGGAAGCUGUGAACGAUCCAAGGUUCUGGGCUCUAGUGGACAAGGAAAGA8729 8920 192
GGGCUGACCCUAAUAGUGGCCAUCAUUUUGCUCGUGGCGCACUACAUGUACUUGAUCCCAGGGCUGCAGGCAGCAGCUGCGCGUGCUGCCCAGAAGAGAACGGCAGCUGGCAUCAUGAAGAACCCUGUUGUGGAUGG7166 7299 134
GGGUUUGGUAUGGGCAAAGGGAUGCCAUUCUACGCAUGGGACUUUGGAGUCCCGCUGCUAAUGAUAGGUUGCUACUCACAAUUAACACCCCUGACCCUAAUAGUGGCCAUCAUUUUGCUCGUGGCGCACUACAUGUACUUGAUCCCAGGGCUG7078 7228 151
GGGCCAUCUAUGCUGCCUUGACAACUUUCAUUACCCCAGCCGUCCAACAUGCAGUGACCACCUCAUACAACAACUACUCCUUAAUGGCGAUGGCCACGCAAGCUGGAGUGUUGUUUGGUAUGGGCAAAGGGAUGCCAUUCUACGCAUGGGACUUUGGAGUCCCGCUGCUAAUGAUA6966 7141 176
GGGAGAAGGGUGAUUCUGCUCAUGGUGCAGGAAGGGUUGAAGAAGAGAAUGACCACAAAGAUCAUCAUAAGCACAUCAAUGGCAGUGCUGGUAGCUAUGAUCCUGGGAGGAUUUUCAAUGAGUGACCUGGCUAAGCUUGCAAUUUUGAUGGGUGCCACCUUCGCGGAAAUGAACACUGGAGGAGAUGUAGC3521 3702 182
GGGAGAAGGGUUUGUUCCAAGCGUGAGGAACGGCAAUGAGAUCGCAGCUUGUCUGACAAAGGCUGGAAAACGGGUCAUACAGCUCAGCAGAAAGACUUUUGAGACAGAGUUCCAGAAAACAAAACAUCAAGAGUGGGACUUUGUCGUGACAACUGACAUUUCAGAGAUGGGCGCCAACUUUAAAGCUGACCGUGUCAUAGAUUCCAGGAGAUGCCUAAAGCCGGUCAUACU5628 5850 223
GGGAGAUCAACCACUGCAAGCGGAAGGGUGAUCGAGGAAUGGUGCUGCAGGGAGUGCACAAUGCCCCCACUGUCGUUCCGGGCUAAAGAUGGCUGUUGGUAUGGAAUGGAGAUAAGGCCCAGGAAAGAACCA3316 3445 130
GGGAGUGGUUCCACGACAUUCCAUUACCUUGGCACGCUGGGGCAGACACCGGAACUCCACACUGGAACAACAAAGAAGCACUGGUAGAGUUCAAGGACGCACAUGCCAAAAGGCAAACUGUCGUGGUUCUAGGGAGUCAAGAAGGAGCAGUUCACACG1555 1711 157
GGGUGGACGCCAGAGUUUGUUCAGAUCAUGCGGCCCUGAAGUCAUUCAAGGAGUUUGCCGCUGGGAAAAGAGGAGCGGCUUUUGGAGUGAUGGAAGCCCUGGGAACACUGCCAGGACACAUGACAGAGAGAU6330 6458 129
GGGCUGCCGGAAUAACCUACACAGAUAGAAGAUGGUGCUUUGAUGGCACGACCAACAACACCAUAAUGGAAGACAGUGUGCCGGCAGAAGUGUGGACCAGACACGGAGAGAAAAGAGUGCUCAAACCGAGGUGGAUGGACGCCAGAGUUUGUUCAGA6198 6351 154
GGGCUACUGGAUUGAGAGUGAGAAGAAUGACACAUGGAGGCUGAAGAGGGCCCAUCUGAUCGAGAUGAAAACAUGUGAAUGGCCAAAGUCCCACACAUUGUGGACAGAUGGAAUAGAAGAGAGUGAUCUGAUCAUACCCAAGUCUUUAGCUGGGC3017 3170 154
GGGCAGCCAGAAUUGCAUGUGUCCUCAUUGUUGUGUUCCUAUUGCUGGUGGUGCUCAUACCUGAGCCAGAAAAGCAAAGAUCUCCCCAGGACAACCAAAUGGCAAUCAUCAUCAUGGUAGCAGUAGGUCUUCUGGGCUUGAUUACCGCCAAUGAACUCGGAUGGUUGGAGAGAACA6702 6874 173
GGGAGCGGACAAGUUGUCACUUACGCUCUUAACACAUUUACCAACCUAGUGGUGCAACUCAUUCGGAAUAUGGAGGCUGAGGAAGUUCUAGAGAUGCAAGACUUGUGGCUGCUGCGGAGGUCAGAGAAAGUGACUAACUGGUUGCAGAGCAACGGAUGGGAUAGGCUCAAACGAAUGG9404 9581 178
GGGUGCUCGGUGGACUUCUCAAAGAAGGAGACGAGAUGCGGUACAGGGGUGUUCGUCUAUAACGACGUUGAAGCCUGGAGGGACAGGUACAAGUACCAUCCUGACUCCCCCCGUAGAUUGGCAGCAGCAGUCAAGCAAGCCUGGGAAGAU2429 2578 150
GGGAGUGGUGCAACUCAUUCGGAAUAUGGAGGCUGAGGAAGUUCUAGAGAUGCAAGACUUGUGGCUGCUGCGGAGGUCAGAGAAAGUGACUAACUGGUUGCAGAGCAACGGAUGGGAUAGGCUCAAACGAAUGGCAG9451 9584 134
GGGCAAUACCAGAGAGGGCUACAGGACCCAAAUGAAAGGGCCAUGGCACAGUGAAGAGCUUGAAAUUCGGUUUGAGGAAUGCCCAGGCACUAAGGUCCACGUGGAGGAAACAUGUGGAACGAGAGGACCAUCUCUGAGAUCAACCACUGCAAGC3184 3334 151
GGGAGUAGGUCUUCUGGGCUUGAUUACCGCCAAUGAACUCGGAUGGUUGGAGAGAACAAAGAGUGACCUAAGCCAUCUAAUGGGAAGGAGAGAGGAGGGGGCAACCAUAGGAUUCUCAAUGGACAUUGACCUGCGG6820 6952 133
GGGAUAGGCUCAAACGAAUGGCAGUCAGUGGAGAUGAUUGCGUUGUGAAGCCAAUUGAUGAUAGGUUUGCACAUGCCCUCAGGUUCUUGAAUGAUAUGGGAAAAGUUAGGAAGGACACACAAGAGUGG9561 9688 128
Target RNA Fragment Used for Initial Sensor Screening
Table S2. Sequences of NASBA Primers Used for Zika RNA Amplication (related to Figure 3 and Figure S2)
NOTES:
1. NASBA experiments on the MR 766 Zika virus were only conducted using NASBA primers for sensor 32B.
A Series B series Forward Reverse
1A 25B AATTCTAATACGACTCACTATAGGGAGAAGGCAGTGATCTAGGCTACTGGACCCAGCTAA GACTT GGTA A
2A 26B AATTCTAATACGACTCACTATAGGGAGAAGGGTGCCAGAGTTGTGTGTACAC TCCAGTGATCCTCGTTCA
3A 27B AATTCTAATACGACTCACTATAGGGAGAAGGGCACAGTGGGATGATCGTTACCT TC T G TCACAATCAA
4A 28B AATTCTAATACGACTCACTATAGGGAGAAGGCGGGATCTCCTCTGTTTCAAA TCT TGT GAC TCTCCA
5A 29B AATTCTAATACGACTCACTATAGGGAGAAGGCCATCACTGGGTCTCATCAAGGC A CA T CC A A TA
6A 30B AATTCTAATACGACTCACTATAGGGAGAAGGAATGCTGTCAGTTCATGGCTCCCACTGTCCTC G TCACAA
7A 31B AATTCTAATACGACTCACTATAGGGAGAAGGATGGTCTCTTCCTGGTTGTGGACC A CCT GGA CGT CA
8A 32B AATTCTAATACGACTCACTATAGGGAGAAGGGACCCTAATAGTGGCCATCACC TCC AAC GGGT CTT A
9A 33B AATTCTAATACGACTCACTATAGGGAGAAGGGTTTGGTATGGGCAAAGGGAC GCCC GGGATCAA TAC T TA
10A 34B AATTCTAATACGACTCACTATAGGGAGAAGGGCCATCTATGCTGCCTTGACAACCCATA CAAACAA ACT CA
11A 35B AATTCTAATACGACTCACTATAGGGAGAAGGGTGATTCTGCTCATGGTGCACTTA CC GGTCA T A
12A 36B AATTCTAATACGACTCACTATAGGGAGAAGGGTTTGTTCCAAGCGTGAGGAA GTT GCGCCCATCTCT AA
13A 37B AATTCTAATACGACTCACTATAGGGAGAAGGAGATCAACCACTGCAAGCGGAATTCTTTCCTGGG CT ATCTCCA
14A 38B AATTCTAATACGACTCACTATAGGGAGAAGGAGTGGTTCCACGACATTCCACCTTCTTGACTC TAGAACCA
15A 39B AATTCTAATACGACTCACTATAGGGAGAAGGTGGACGCCAGAGTTTGTTCAGAATCTC CTGTCATGT TCC GGCA
16A 40B AATTCTAATACGACTCACTATAGGGAGAAGGGCCGGAATAACCTACACAGATCT AA AAACTCTGGCGT CA
17A 41B AATTCTAATACGACTCACTATAGGGAGAAGGGGCTACTGGATTGAGAGTGAGACCCA CTA AGACT G GT TGA
18A 42B AATTCTAATACGACTCACTATAGGGAGAAGGCAGCCAGAATTGCATGTGTCCTCATGTTCTCTCCAACCATCCGA
19A 43B AATTCTAATACGACTCACTATAGGGAGAAGGGGAGCGGACAAGTTGTCACTTACTCT C A CAGTTAGTCA
20A 44B AATTCTAATACGACTCACTATAGGGAGAAGGGTGCTCGGTGGACTTCTCAAAGAAATCTTCCCAGGCTTGCTTGA
21A 45B AATTCTAATACGACTCACTATAGGGAGAAGGAGTGGTGCAACTCATTCGGATGCCATTC TTTGAGCCTATC CA
22A 46B AATTCTAATACGACTCACTATAGGGAGAAGGCAATACCAGAGAGGGCTACAC TGGT GATCTCAGA A
23A 47B AATTCTAATACGACTCACTATAGGGAGAAGGAGTAGGTCTTCTGGGCTTGACGCA GTC ATGTCCA T AGA
24A 48B AATTCTAATACGACTCACTATAGGGAGAAGGGCTCAAACGAATGGCAGTCACC CTCTTGTGTGTCC TCCTA
NASBA Primers for Zika Virus from the Americas (KU312312)Toehold Switch Sensor
Table S2
Table S2. Sequences of NASBA Primers Used for Zika RNA Amplication (related to Figure 3 and Figure S2)
Forward Reverse
AATTCTAATACGACTCACTATAGGGAGAAGGGCACAGTGGGATGATCGTTACCTGTCCT GGTTCACA C A
AATTCTAATACGACTCACTATAGGGAGAAGGACTCTGATAGTAGCTATCACCATCCACAACGGG TTCTTCA
NASBA Primers for MR 766 Zika Virus (AY632535)
Table S3. Portable electronic reader build of materials (related to Figure 4 and Figure S4)
total $ : 244.238
Vendor quantity price total price item # description
Adafruit 1 24.95 24.95 50 Arduino Uno R3 (Atmega328 - assembled)
Adafruit 1 19.95 19.95 2078 Adafruit PowerBoost 500 Shield - Rechargeable 5V Power Shield
Adafruit 1 12.5 12.5 2011 Lithium Ion Battery - 3.7v 2000mAh
Adafruit 1 19.95 19.95 1141 Adafruit Assembled Data Logging shield for Arduino
Adafruit 1 7.95 7.95 102 SD/MicroSD Memory Card (4 GB SDHC)
Adafruit 16 6.26 100.16 1980 Adafruit TSL2591 High Dynamic Range Digital Light Sensor
Sparkfun 3 2.8 8.4 PRT-12702 SparkFun Solder-able Breadboard - Mini
Digi-Key 2 0.49 0.98 A19473-ND CONN HEADER VERT 9POS .100 TIN
Digi-Key 2 0.643 1.286 A19476-ND CONN HEADER VERT 13POS .100 TIN
Digi-Key 2 1.21 2.42 A31001-ND CONN RECEPT 9POS 28AWG MTA100
Digi-Key 2 1.93 3.86 A30954-ND CONN RECEPT 13POS 28AWG MTA100
Digi-Key 20 0.2246 4.492 36-621-ND BRACKET RT ANG MOUNT 4-40 STEEL, for reader assembly
McMaster-Carr 1 2.36 2.36 90760A005 Zinc Plated Steel Narrow Hex Nut 4-40 Thread Size, 3/16" Wide, 1/16" High, for reader assembly
McMaster-Carr 1 6.74 6.74 8505K11 Black Acrylic, for reader
McMaster-Carr 2 8.04 16.08 92095A453 M2 screws, for attaching sensors
McMaster-Carr 1 1.04 1.04 90592A004 M2 nuts, for attaching sensors
Inventables 1 4.84 4.84 23876-35 Clear acrylic, for bottom half of cassette
Inventables 1 6.28 6.28 24112-04 Black acrylic, for top half of cassette
Table S3
Table S3. Portable electronic reader build of materials (related to Figure 4 and Figure S4)
Arduino Uno R3 (Atmega328 - assembled)
Adafruit PowerBoost 500 Shield - Rechargeable 5V Power Shield
Lithium Ion Battery - 3.7v 2000mAh
Adafruit Assembled Data Logging shield for Arduino
SD/MicroSD Memory Card (4 GB SDHC)
Adafruit TSL2591 High Dynamic Range Digital Light Sensor
SparkFun Solder-able Breadboard - Mini
CONN HEADER VERT 9POS .100 TIN
CONN HEADER VERT 13POS .100 TIN
CONN RECEPT 9POS 28AWG MTA100
CONN RECEPT 13POS 28AWG MTA100
BRACKET RT ANG MOUNT 4-40 STEEL, for reader assembly
Zinc Plated Steel Narrow Hex Nut 4-40 Thread Size, 3/16" Wide, 1/16" High, for reader assembly
M2 screws, for attaching sensors
M2 nuts, for attaching sensors
Clear acrylic, for bottom half of cassette
Black acrylic, for top half of cassette
pwr pwr
gnd gnd
s0 s0
s1
s1
s2
s3 s2
data s3
clock LED
Last→ 
First ↓
Last→ 
First ↓
ACA ACC ACG ACT ACA AAC AAG AAT
AGA AGC AGG AGT AGA AGC AGG AGT
ATA ATC ATG ATT ATA ATC ATG ATT
CCA CCC CCG CCT CAA CAC CAG CAT
CGA CGC CGG CGT CGA CGC CGG CGT
CTA CTC CTG CTT CTA CTC CTG CTT
GCA GCC GCG GCT GAA GAC GAG GAT
GGA GGC GGG GGT GGA GGC GGG GGT
GTA GTC GTG GTT GTA GTC GTG GTT
TCA TCC TCG TCT TAA TAC TAG TAT
TGA TGC TGG TGT TGA TGC TGG TGT
TTA TTC TTG TTT TTA TTC TTG TTT
Last→ 
First ↓
Last→ 
First ↓
AAA AAC AAG AAT AAA AAC AAG AAT
ACA ACC ACG ACT ACA ACC ACG ACT
ATA ATC ATG ATT AGA AGC AGG AGT
CAA CAC CAG CAT CAA CAC CAG CAT
CCA CCC CCG CCT CCA CCC CCG CCT
CTA CTC CTG CTT CGA CGC CGG CGT
GAA GAC GAG GAT GAA GAC GAG GAT
GCA GCC GCG GCT GCA GCC GCG GCT
GTA GTC GTG GTT GGA GGC GGG GGT
TAA TAC TAG TAT TAA TAC TAG TAT
TCA TCC TCG TCT TCA TCC TCG TCT
TTA TTC TTG TTT TGA TGC TGG TGT
T
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Table S4. Probabilities of PAM site disruption from single point mutations (Related to Figure 5 and Figure S5).
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Center letter: A Center letter: C
Center letter: TCenter letter: G
B. Detailed list of all single point mutations on every 3-bp sequences.
A. Summary of the effect of single point mutations
TAT
CAT
AAT
CCT
TCT
C
GCT
12 PAM sites
4 double PAM sites
32 PAM site created
12 double PAM site created
32 PAM site destroyed
12 double PAM site destroyed
4 PAM site inverted
Overall, any given point mutations has a 48% probability (92/192) of disrupting an existing PAM site.   
Each mutation has a 23% probability (44/192) of creating a new PAM site, a 23% probability (44/192) of destroying and existing PAM site, and a 
2% probability (4/192) of inverting the orientation of an existing PAM site.
1
Table S4
4 PAM site inversions
4 double PAM sites
Table S1
All 64 3-gram sequences create 20 PAM sites. A single point mutation will change the 3-gram’s middle base. Each mutation has a 23% probability (44/192) of creating a new PAM site, a 23% probability (44/192) of destroying and existing PAM site, and a 2% probability (4/192) of inverting the orientation of an existing PAM site. 
Overall, any given point mutations has a 48% probability (92/192) of disrupting an existing PAM site.   
12 double PAM site creations
12 double PAM site destructions
12 PAM sites
32 PAM site creations
32 PAM site destructions
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gRNA-1 cttcagcctccagtacagcgcgg 717 antisense 86.6
gRNA-2 gttcccacggagaatccgacggg 360 sense 90.9
gRNA-3 ctgcgatgtcggtttccgcgagg 1001 sense 88.6
gRNA-4 tggaagatcaggatatgtggcgg 610 sense 80.0
gRNA-5 ttaacgcctcgaatcagcaacgg 1051 antisense 88.4
gRNA-6 gcgcgtcgtgattagcgccgtgg 1398 antisense 86.8
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